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The Administrative Data 
Component of the Pre-Paid 
Managed Care Evaluation: 
Year 11 
 
Executive Summary 
 
     During FY 2006-2007 we had the opportunity to begin the evaluation of 
managed behavioral health care as it emerged from “pilot status” to statewide 
implementation.  We looked at the performance of the HMOs and pre-paid 
mental health plans (PMHP), comparing access to services and outcomes of 
individuals for six months prior to and subsequent to the plans assuming 
responsibility for their care.  We also studied the timeliness and 
appropriateness of care delivered to enrollees in each of the plans that were 
discharged from psychiatric hospital care.  This year we use essentially the 
same methods to evaluate the ongoing performance of the plans serving areas 
5 and 7 and the performance of managed care plan start-ups in areas 2, 3 and 
11. 
 
     Like last year, this year’s service penetration and outcomes analysis 
concentrates on the performance of plans in serving adults with a serious 
mental illness (SMI) and children with a serious emotional disturbance (SED).  
These are the populations most likely to need mental health services and 
supports.  They are also the most likely to experience changes in outcomes in 
response to short term modifications in service access.   
 
Summary Penetration and Density Analyses 
 
     For children with an SED in areas 2, 3 and 11, there were significant 
declines in penetration rates for both categories of ambulatory care – 
psychiatric office visits and community mental health.  Although penetration 
rates for psychiatric office visits increased overall with the implementation of 
managed care in areas 5, 7 and 11, these increases tended to be more than 
offset by corresponding reductions in community mental health services.  The 
same was true of service density where the modest increases in the density of 
psychiatric office visits were most often more than offset by declines in 
community mental health service density. 
Moreover, contrary to expectations that managed care implementation would 
shift care from more expensive inpatient to less expensive ambulatory care, 
penetration of inpatient care for children with an SED actually increased 
overall in areas 3, 5 and 7.  Access issues are particularly troublesome for the 
PMHPs. Access to psychiatric office visits declined for these plans in areas 5, 
7, 2 and 3, while penetration rates for HMOs tended to increase.  However, 
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rather than seeing offsetting increases in community mental health service 
penetration with the implementation of managed care, we also observed 
significantly greater declines in penetration rates for community mental health 
services for enrollees in these plans compared to the HMOs. 
     The experience of adults with an SMI accessing mental health services 
parallels, the experience of children with an SED.  For this population as well, 
we did not observe an overall shift from inpatient to outpatient care.  With 
regard to ambulatory care, there were overall increases in psychiatric office 
visit penetration rates in all areas except area 2.  However, all areas 
experienced significant overall declines in community mental health services 
penetration.  In some areas, these declines were largely offset by increases in 
psychiatric office visits.  In other areas (areas 2 and 11), they clearly were not. 
     The performance of the PMHPs was also problematic for adults with a 
SMI.  Penetration of psychiatric office visits declined in all areas except area 
11.  Community mental health service penetration also declined in all areas, 
with the largest reductions occurring in areas 2 and 3. 
 
Summary Quality of Care 
 
     Providing follow-up ambulatory services to patients discharged from 
hospital care is a basic indicator of quality of care for managed care plans.  In 
the first six months following managed care implementation, six out of eight 
of the plans serving areas 5 and 7 were below the 50% percentile of Medicaid 
HMO plans reporting on this HEDIS measure.  None of the plans 
approached the 75th percentile of 71% follow-up care within 30 days.  
Although there was consistent, improvement during the second six month 
post implementation period, two of the plans remained below the 50th 
percentile and only 3 of 8 reached the 75th percentile of Medicaid HMO’s 
reporting on this HEDIS measure.  Clearly there is room for continued 
improvement in providing short term follow-up care to hospital discharges. 
     Performance was somewhat better during the first 6 month periods among 
the plans serving areas 2, 3 and 11 with sufficient numbers of hospital 
discharges. All but one plan were at or above the 50th percentile.  No plan 
approached the 75th percentile although in view of the improvements in 
performance observed in areas 5 and 7 in the second six month managed care 
period, there is reason to hope most of the plans will move close to or exceed 
the 75th percentile in the second six months. 
     Not surprisingly, larger percentages of patients discharged from hospital 
care received outpatient services in the 3-6 month periods following 
discharge. However, plan performance was not uniform. Amerigroup in both 
areas 5 and 7 and HE in area 7 reached less than 70% of their discharged 
enrollees in the first 6-month follow up period. As was the case with 30-day 
follow up rates, the performances of plans generally improved in the second 
6-month period following managed care implementation. 
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     Performance on the delivery of follow up outpatient care during the 3-6 
month period after hospital discharge for the plans serving areas 2 and 3 were 
similar to that of Amerigroup and HE in areas 5 and 7 with all plans reaching 
less than 70% of discharged enrollees. Area 11 rates were more consistent 
with those observed in the first 6-month follow up periods in areas 5 and 7. 
     Generally, 15-20% of patients discharged from inpatient care were 
readmitted to deep end services during the 3-6 month follow up periods. 
Comparing performance in the first 6-month post implementation period to 
the second for areas 5 and 7, we did not observe consistent improvements. In 
fact, the performance of Amerigroup deteriorated notably from the first to 
the second period. In the later managed care implementation areas, the 
performance of Magellan and the PH Trust in area 11 were particularly 
problematic. One third of enrollees discharged from hospital care during the 
first six months of managed care implementation were readmitted to deep end 
services in the 3-6 months following discharge. 
 
Outcomes Summary 
     This year’s outcomes analysis does not identify significant differences in 
the rates of Baker Act evaluations and arrests pre to post managed care 
implementation although the performances of SW in area 3 and HE in area 11 
with adults with an SMI warrant ongoing monitoring.  
 
Background 
 
    During FY 2006-2007 we had the opportunity to begin the evaluation of 
managed behavioral health care as it emerged from “pilot status” to statewide 
implementation.  We looked at the performance of the HMOs and pre-paid 
mental health plans (PMHP), comparing access to services and outcomes of 
individuals for six months prior to and subsequent to the plans assuming 
responsibility for their care.  We also studied the timeliness and 
appropriateness of care delivered to enrollees in each of the plans that were 
discharged from psychiatric hospital care.  This year we use essentially the 
same methods to evaluate the ongoing performance of the plans serving areas 
5 and 7 and the performance of managed care plan start-ups in areas 2, 3 and 
11.  Actual implementation dates and, therefore, the beginning and end points 
for the six month baselines and post implementation periods are presented in 
Table 1. 
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 Table 1: Begin and End dates for Baseline and Post-Implementation Periods for  
Service and Outcomes Analyses. 
 Baseline Period
Begins 
First Post-
Implementation 
Period Begins 
(Implementatio
n Date) 
 
Second Post-
Implementation 
Period 
Begins 
Area 5  
Florida Health 
Partnership (FHP) 
2/1/05-7/31/05 8/1/05-1/28/06 2/1/06-7/31/06
Amerigroup 10/1/04-3/30/05 4/1/05-9/28/05 10/1/05-3/30/06
Healthease 11/1/04-4/30/05 5/1/05-10/28/05 11/1/05-4/30/06
Staywell 11/1/04-4/30/05 5/1/05-10/28/05 11/1/05-4/30/06
Area 7  
Florida Health 
Partnership (FHP) 
2/1/05-7/31/05 8/1/05-1/28/06 2/1/06-7/31/06
Amerigroup Orange, 
Osceola, 
Seminole  
9/1/04-2/28/05 3/1/05-8/28/05 9/1/05-2/28/06
Brevard 1/1/05-6/30/05 7/1/05-12/28/05 1/1/06-6/30/06
Healthease 
 
Orange, 
Osceola, 
Seminole  
10/1/04-3/30/05 4/1/05-9/28/05 10/1/05-3/30/06
Brevard 3/1/05-8/28/05 9/1/05-2/28/06 3/1/06-8/28/06
Staywell Orange, 
Osceola, 
Seminole 
10/1/04-3/30/05 4/1/05-9/28/05 10/1/05-3/30/06
Brevard 3/1/05-8/28/05 9/1/05-2/28/06 3/1/06-8/28/06
 
 Baseline Period
Begins 
1st Post-Implementation 
Period Begins 
(Implementation Date) 
 
Area 2  
Magellan 4/1/06-9/28/06 10/1/06-3/30/07
Buena Vista1 4/1/06-9/28/06 10/1/06-3/30/07
Healthease 12/1/04-5/30/05 6/1/05-11/28/05
Area 3 
NFBHP 4/1/06-9/28/06 10/1/06-3/30/07
Healthease  11/1/04-4/30/05 5/1/05-10/28/05
Staywell 11/1/04-4/30/05 5/1/05-10/28/05
United1 3/1/05-8/28/05 9/1/05-2/28/06
Area 11 
Amerigroup1 12/1/04-5/30/05 6/1/05-11/28/05
PH Trust 2/1/06-7/31/06 8/1/06-1/28/07
Magellan 2/1/06-7/31/06 8/1/06-1/28/07
Healthease 3/1/05-8/28/05 9/1/05-2/28/06
Staywell 3/1/05-8/28/05 9/1/05-2/28/06
 
                              The Administrative Data Component of the Pre Paid Managed Care Evaluation: Year 11 ? 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Like last year, this year’s service penetration and outcomes analysis 
concentrates on the performance of plans in serving adults with a serious 
mental illness (SMI) and children with a serious emotional disturbance (SED).  
The operational definitions of these groups are included in Appendix 1 of this 
report.  These are the populations most likely to need mental health services 
and supports.  They are also the most likely to experience changes in 
outcomes in response to short term modifications in service access.  For the 
evaluation this year, susceptibility to short term changes in care management 
are particularly important, because the study only includes data for the six-
month periods for areas 2, 3 and 11 that occurred immediately after the plans 
assumed responsibility for care.  Over the long term a variety of individuals 
will need to access mental health care from their health plans. However, 
within six-month transition time frames, it is much more likely that adults 
with an SMI and children with an SED will require such care, and be 
impacted by the actions or inactions of their health plans. 
 
Study Questions 
 
The primary study questions for this years work are the following: 
1. Did overall access to inpatient and ambulatory mental health care in 
implementation areas change for children with a severe emotional 
disturbance (SED) and adults with a serious mental illness (SMI) from 
the pre-implementation period to the six and twelve months 
immediately following managed care implementation?   
 
2. If so, what were the directions and nature of these changes? 
 
3. Did access to inpatient and ambulatory mental health care in areas 2, 
3, 5, 7, and 11 change differently from the pre to the implementation 
periods for children with a severe mental illness (SED) and adults with 
an SMI served by different managed care plans? 
 
4. Did rates of Baker Act evaluations in areas 2, 3, 5, 7, and 11 change 
differently from the pre to the post-managed care implementation 
periods for children with an SED and adults with an SMI served by 
different managed care plans? 
 
5. Did arrest rates in areas 2, 3, 5, 7, and 11 change differently from the 
pre to the post-managed care implementation periods for children 
with an SED and adults with an SMI served by different managed care 
plans? 
 
6. Do managed mental health care plans in Areas 2, 3, 5, 7 and 11 differ 
in terms of the percentages of inpatient admissions that received 
ambulatory mental health care in the 30 days and 3-6 months after 
discharge? 
 
7. Did enrollees in the different plans who were discharged from     
hospital care have different readmission rates in the 3-6 months 
following discharge? 
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Service Penetration and Density Analyses 
 
     For health plans to effectively serve their recipients, they must first provide 
access to those needing care.  Recipients must be able to engage network 
providers and receive the services and supports they require.  It is therefore, 
relevant to ask if recipients’ utilization of mental health services changed from 
the baseline to the post-implementation periods.  It is also reasonable to 
compare the service utilization of recipients in the different health plans 
during the post-implementation period.  We cannot know for sure that 
increases or decreases in service utilization over time are the result of plan 
policies and actions.  They could, in fact, reflect changes in the needs of plan 
enrollees.  Large changes in utilization patterns over short periods of time, 
however, are more likely the result of service access issues than real 
expressions of changing need.  
     We use service penetration as the measure of access to mental health 
services.  From a common sense point of view, service penetration is the 
number of individuals that accessed a service during a particular time interval, 
in this case, six-month baseline and six and 12 months post-implementation, 
divided by the total number of people that could have accessed the service.  
However, in the context of health plans the number of months individuals are 
enrolled is important since a service cannot be accessed from a network 
provider if the individual is not enrolled in the plan.  Therefore, we measure 
penetration as the number of eligible months of enrollees that accessed 
particular categories of service during the six-month periods divided by the 
total number of eligible months of all individuals that could have accessed the 
same category of service. 
     Although there likely is a significant overlap in the individuals served by 
each plan in the six-month periods, the analysis does not require them to be 
the same.  We are comparing the service penetration of all individuals meeting 
the SMI and SED criteria in each of the plans during the baseline and post-
implementation periods, rather than the behavior of the same individuals over 
time. 
     The service categories used in this year’s service access analysis include 
psychiatric inpatient care, psychiatric office visits and community mental 
health (CMH).  The CMH category includes the wide array of outpatient 
services and supports available to children with an SED and adults with an 
SMI who are enrolled in the Medicaid program.  
     For the first time, in last year’s evaluation we used the concept of service 
frequency or density as a means of enhancing the precision of our 
measurement of access beyond the simple penetration rates used in the past. 
Service density refers to the average number of days per enrolled month that 
enrollees who penetrated a service in a particular category used that particular 
service. As with the penetration analysis, the denominator in service density 
calculations is the total eligible months of service users during the period in 
question. The combined use of service penetration and density tells us (a) if a  
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service was accessed any time during a specified period and (b) how 
frequently it was accessed on average during the time period.  
     The primary questions in the penetration and density analysis are the 
following:   
 
1. Did services penetration rates and densities increase or decrease for 
children with an SED and adults with an SMI comparing the pre-
implementation periods to the post-implementation periods. 
 
2. Did penetration rates and service density differ for the various plans 
serving each area?  For example, did penetration of inpatient 
psychiatric services increase for children with an SED in one plan and 
decrease in another?  Did children with an SED that received 
psychiatric office visits in each of the plans receive them more or less 
frequently in the pre compared to the post-implementation periods? 
 
     Penetration and service density results are reported separately for all areas 
for children with an SED and for adults with an SMI.  Plan comparisons as 
described in #2 above are analyzed by comparing all plans in an area to a 
single reference group.  For example, the change in community mental health 
penetration rates pre to post-managed care implementation for each of the 
plans is compared to the change in a reference group.  In area 2 the reference 
group is Magellan, in area 3 it is North Florida Behavioral Health Plan and in 
areas 5 and 7 it is Florida Health Partnership. In area 11 the reference group is 
the Public Health Trust (PH Trust). These plans are referred to collectively as 
the pre paid mental health plans. (PMHP) 
 
     The statistical analysis used the SAS GENMOD procedure to perform 
logistic regression analyses on services penetrations and densities with an 
autoregressive component, which accounted for persons having repeated 
observations when they were eligible for more than one time period.  For 
penetration, the logistic regression modeled the probability that a person 
served by a particular plan penetrated a service in their eligibility period 
compared to the reference group as defined above. It used eligible months as 
a frequency variable.  This gave more weight to the observations where a 
person was eligible for more months.  For service density, the analysis 
modeled the probability that a person used a service on a given day.  The 
logistic regression used a response/trials approach where the number of days 
in the eligibility period that a particular service was used was the response, and 
the number of days of eligibility in that period was the trials variable.  Both 
analyses included Group, Time and the Group by Time interaction.   
     The Group effect tested whether or not each HMO plan differed 
significantly from the PMHP reference group.  The time effect tested whether 
or not each post-implementation period was different from the pre-
implementation period.  The group by time interaction tested whether or not 
each HMO plan’s interaction was significantly different from the interaction 
of the PMHP reference group.  In Area 11, where there were two PMHP 
plans, PH Trust was employed as the reference group and the analysis
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tested whether or not Magellan and each of the HMOs differed from the PH 
Trust. 
 
Children with an SED 
 
     There was a tendency for penetration of psychiatric inpatient care to 
increase pre to post-managed care implementation, with significant main 
effects of time observed in area 5 (P< .0001) 7 (P = .003) and 3 (P=.04).  In 
area 5, there was also a significant group by time interaction with Florida 
Health Partnership (FHP) and Amerigroup rates increasing, while Healthease 
(HE) and Staywell (SW) rates decreased pre to post implementation. In area 
11, there was a significant plan by time interaction with Magellan and 
Healthease (HE). In these plans enrollees experienced declining inpatient 
penetration rates pre to post managed care implementation, while rates for the 
PH Trust and Staywell (SW) increased. 
 
     Density of inpatient care generally did not change pre to post managed 
care implementation.  One exception was in area 11, where the density of 
inpatient care of HE inpatients declined significantly more than those covered 
by the Public Health Trust. 
     Penetration rates for psychiatric office visits increased pre to post managed 
care in all areas. The main effects of time were significant for areas 2, 3, 5 and 
7 (P<.0001).  However, there were also significant plan by time interactions in 
all areas. These interactions generally indicated declines in psychiatric office 
visit penetration over time for the prepaid mental health plans (PMHPs), and 
stable or increasing rates for one or more of the HMOs. The one exception 
was in area 11, where penetration declined for one of the two HMOs as well 
as for Magellan and the PH Trust.  In area 5, the FHP penetration rates in the 
pre and second six-month post periods were almost identical.  SW and 
Amerigroup experienced significant increases in penetration over these two 
periods compared to FHP.  In area 2, the rates of change were significantly 
different for the two plans, with HE increasing while Magellan decreased.  In 
area 3, changes in penetration rates over time were also significantly different, 
with North Florida Behavioral Health Plan (NFBHP) decreasing while HE 
increased slightly and SW rates remained constant.  
 
     There were also significant main effects of time for psychiatric office visits, 
with density increasing in all areas except area 7.  There were also significant 
plan by time interactions in areas 2, 3, 5 and 11.  In areas 2, 3 and 5 the 
PMHPs had higher densities in the pre-period.  However, over time their 
densities decreased while HMO psychiatric office visit density increased. This 
was also true in area 11. However, in this area service density decreased for 
SW, an HMO. 
     Significant main effects of time were observed for community mental 
health services.  Generally penetration rates declined over time in all areas. 
The plan by time interactions that were observed indicated that the magnitude 
of the reductions in penetration rates pre to post managed care  
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 implementation were greater for the PMHPs compared to the HMOs, even 
though the penetration rates for the former were not consistently higher in 
the pre managed care period.  Figure1 presents the penetration rates over time 
for areas 2, 3 and 7.   
Figure 1: SED Child CMH Penetration Areas 2, 3, and 7
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      We can see in Figure 1 that the penetration rates for CMH services for 
FHP in area 7 declined by 11 percentage points. (Pre to post differences were 
significant at P<.0001) while penetration rates for the HMOs remained 
relatively stable. The change in penetration pre to post implementation for 
each of the HMOs was significantly less than for the PMHP (P<.0001). 
Similar trends are observed for area 3 and area 7, with the PMPH plans 
declining significantly more over time than the HMOs. We also see in Figure 
3 significant variations in penetration by area. Penetration rates of CMH 
services in area 7 are significantly lower than the rates in areas 2 and 3. Data 
for the remaining areas are included in Appendix 1. 
     There were several group by time interactions in the density of community 
mental health services.  In areas 5 and 7, the changes in density pre to the 
second six month post periods declined significantly less for the HMOs 
compared to the FHP.  In area 11, all plans declined significantly more than 
the Public Health Trust.  In area 3 there were not significant differences in 
changes in service density for NFBHP relative to the two HMOs serving the 
area. 
 
Figure 1. SED Child CMH Penetration Areas 2, 3, and 7
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Adults with a Serious Mental Illness 
 
     For the most part, access to inpatient psychiatric care did not change from 
pre to post managed care implementations for enrollees with an SMI enrolled 
in HMOs or in PMHPs.  The one exception was area 3, where there was a 
significant main effect of time indicating an overall increase in penetration of 
inpatient care pre to post managed care.  In area 3 there were no significant 
plan by time interactions, although clearly SW and NFBHP were responsible 
for the overall main effect increasing from 7.7% to 12.7% for SW and from 
5.7% to 9.6% for NFBHP while HE increased by less than 1 %.  There were 
no significant differences among the plans pre to post managed care in the 
density of inpatient services. 
     For adults with a SMI, when we compare penetration of psychiatric office 
visits pre and post managed care implementation of the HMOs and PMHPs, 
we tend to find significant main effects of time, with penetration of office 
visits increasing pre to post managed care implementation. 
     However, we also find significant group by time interactions.  Penetration 
rates for HMO enrollees tended to increase as managed care was 
implemented, and rates remained the same or decreased for the PMHPs.  
Table 2 presents psychiatric office visit penetration rates over time for areas 3 
and 5.  
 
Figure 2.  Adult SMI Psychiatric Office Visit Penetration Areas 3 & 5
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     We can see in Figure 2 that in area 5, there were significant differences 
between each of the HMOs and FHP in the nature of changes in penetration 
from pre to post managed care implementation. Rates for FHP declined from 
25.5% in the six months prior to implementation to 10.13% during the 6-12 
month period of managed care.  In contrast, Amerigroup penetration 
increased from 18.9% to 33%, HE from 35.6% to 38.5%, and SW from 33.5 
to 44.7%. Also in area 3, the PMHP penetration rate dropped from 17% to 
10% while the rate for SW nearly doubled, and the rate for HE remained 
constant. In all areas except area 11, the penetration rates for office visits in 
the post period were lower for the PMHPs compared to all the HMOs 
servicing the area. In area 11 this was true for Magellan, one of the two 
PMHPs serving the area. It was not true for the PH Trust that had the highest 
penetration rate for psychiatric office visits in the post period. 
 
     There were significant main effects of time for the density of psychiatric 
office visits in all areas, with density generally increasing from the pre to the 
post period. Once again, there were significant group by time interactions 
with the density of psychiatric office visits increasing for the HMOs and 
decreasing for the PMHPs. In area 11, the decline was observed for both 
Magellan and the PH Trust. 
     There were significant main effects of time for community mental health 
services density in all areas. This effect was toward overall reductions in 
penetration of community mental health services.  There were also significant 
plan by time interactions.  However, they were not consistent across the areas.  
In areas 5 and 3 service density for the PMHP increased from pre to post 
managed care implementation, while they declined for all the HMOs.  
Comparing the changes from pre managed care to 6-12 months post managed 
care in area 5, there were significant differences between FHP and 
Amerigroup (P=.0003, HE (P=.02) and SW (P=.01).  In area 3, penetration 
rates for NFBHP increased from 53% in the pre to 58% in the post managed 
care period.  This change was significantly different from SW (P=.04) which 
declined from 57% to 46%, but not from HE which declined from 61% to 
59%.  However, in area 2 there was a significant group by time interaction 
with service density for the PMHP dropping more than HE pre to post 
managed care (Magellan 59% → 41%) (HE 77% →74%). 
     With regard to the density of community mental health services, there 
were main effects of time, with density declining significantly in all areas and 
in all plans with the exception of area 5.  Although in area 5, the main effect 
of time was not significant, service density declined for all plans. 
 
Summary Penetration and Density Analyses 
 
     Since there are no standards for appropriate penetration rates and service 
densities for children with an SED and adults with an SMI, we cannot 
conclude from these analyses that the implementation of managed care 
reduced access of these vulnerable populations to inappropriately low or 
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harmful levels.  However, there are reasons for significant concern. For 
children with an SED in areas 2, 3 and 11, there were significant declines in 
penetration rates for both categories of ambulatory care – psychiatric office 
visits and community mental health.  Although penetration rates for 
psychiatric office visits increased overall with the implementation of managed 
care in areas 5, 7 and 11, these increases tended to be more than offset by 
corresponding reductions in community mental health services.  The same 
was true of service density where the modest increases in the density of 
psychiatric office visits were most often more than offset by declines in 
community mental health service density. 
 
     Moreover, contrary to expectations that managed care implementation 
would shift care from more expensive inpatient to less expensive ambulatory 
care, penetration of inpatient care for children with an SED actually increased 
overall in areas 3, 5 and 7.  No area exhibited a significant main effect of time 
in which penetration of inpatient services declined significantly pre to post 
managed care. 
     Access issues are particularly troublesome for the PMHPs. Access to 
psychiatric office visits declined for these plans in areas 5, 7, 2 and 3, while 
penetration rates for HMOs tended to increase.  However, rather than seeing 
offsetting increases in community mental health service penetration with the 
implementation of managed care, we also observed significantly greater 
declines in penetration rates for community mental health services for 
enrollees in these plans compared to the HMOs. 
The experience of adults with an SMI accessing mental health services 
parallels, in many ways, the experience of children with an SED.  For this 
population as well, we did not observe an overall shift from inpatient to 
outpatient care.  In three of the five areas, there were significant main effects 
of time with penetration of inpatient services increasing from pre to post 
managed care implementation. 
     With regard to ambulatory care, there were overall increases in psychiatric 
office visit penetration rates in all areas except area 2.  However, all areas 
experienced significant overall declines in community mental health services 
penetration.  In some areas, these declines were largely offset by increases in 
psychiatric office visits.  In other areas (areas 2 and 11), they clearly were not. 
     With regard to service access, the performance of the PMHPs was also 
problematic for adults with an SMI.  Penetration of psychiatric office visits 
declined in all areas except area 11.  Community mental health service 
penetration declined in all areas, with the largest reductions occurring in areas 
2 and 3. 
 
Quality of Care 
 
In this years evaluation we studied the service utilization patterns of 
individuals who were discharged from inpatient services in an effort to 
measure and compare the quality of care offered by the different plans 
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servicing areas 5 and 7 and areas 2, 3 and 11.  Service utilization patterns were 
measured in the following ways 
1.  The percentage of plan enrollees that were hospitalized with a 
psychiatric diagnosis who received any ambulatory behavioral 
health service within 30 days of discharge. (Analogous to the 
HEDIS measure of health plan performance, but less restrictive.  
Any outpatient or targeted case management service was counted 
in this analysis while HEDIS measures focus on specific 
providers) 
2. The percentages of the groups described above that received 
ambulatory care in 3-6 months following discharge. 
3. Among those that did receive post-hospital discharge ambulatory 
services, the percentages that received 2, 3 or 4 or more different 
components or types of community based services. (The service 
components used in these analyses are included in Appendix 1) 
 
     The analyses are based on the assumption that individuals discharged from 
inpatient care with a psychiatric diagnosis should have at least one ambulatory 
follow-up visit within 30 days of discharge.  We additionally assumed that the 
follow-up services should continue with some regularity during the 3-6 
months post discharge and ideally should be composed of a variety of 
ambulatory services.  
 
     A key measure of the overall success of follow-up services delivered after 
discharge from inpatient care is whether the individuals involved were able to 
remain out of the hospital during the period immediately following discharge.  
Therefore, in addition to follow-up service rates, we also studied 3-6 month 
readmission rates of those discharged from inpatient care. 
 
     All of these analyses are organized by health plan by AHCA area so that 
we can discern differences in the performance of plans in serving enrollees in 
this high risk, high service need group in different parts of the state. 
 
     A variety of strategies are used to analyze these data.  First, we present the 
simple percentages for each of the plans and indicators across all the areas in 
which they served enrollees.  Second, in analyzing 30 and 90-180 day follow-
up, we compare the percentages of discharged enrollees in each of the plans 
for each of the two periods to the pooled average of all of the plans.  We then 
test the hypothesis that there are no differences between the performance of 
each plan and the pooled average of all the plans. To test group differences in 
the probability of getting an outpatient service within thirty days of discharge, 
we conducted a logistic regression using PROC GENMOD using the FHP in 
the area as the reference group.  As in previous analyses, we included the 
autoregressive component for any person who had multiple inpatient stays 
where more than two time periods were considered.  In addition, groups with 
less than 20 inpatient stays in any time period were deleted from the statistical 
analysis.   
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     In analyzing the number of different ambulatory care components received 
by inpatient discharges from the plans we use generalized linear regression to 
determine if there are plan differences in the average number of components 
offered to enrollees in each of the HMO’s compared to the prepaid 
behavioral health plans. 
  
     Finally, the analysis of readmission rates compares the rates for each plan 
to the pooled readmission rates for all plans serving the areas in question.  
 
     Table 2 presents the data on ambulatory service delivery following hospital 
discharge for the plans serving areas 5 and 7 for the first and second 6-month 
periods after managed care implementation. 
 
Table 2. Follow-up care to persons discharged from inpatient care within 30 days 
 Total hospital 
Discharged 1st 
6 months 
% receiving 
care 
Total hospital 
discharged 2nd 
6 months 
% receiving 
care 
Am5 104 42% 113 62% 
FHP5 250 65% 230 67% 
HE 5 40 50% 44 77% 
SW 5 63 54% 59 75% 
Am 7 90 43% 81 53% 
FHP 7 266 59% 230 71% 
HE 7 98 49% 93 51% 
SW 7 144 51% 124 57% 
 
     In looking at Table 2 we can see that there was relative consistency in the 
performance of each of the plans in the two areas.  In the first 6 month post 
managed care implementation period,  Amerigroup provided services for 
slightly over 40% of enrollees discharged from inpatient care and was well 
below the 50th percentile of Medicaid plans reporting on this HEDIS  measure 
(55%) in both areas 5 and 7.  HE and SW were also at or below the 50th 
percentile in both areas, while FHP was slightly above the 50th percentile in 
area 7, and well above it in area 5.   
 
     Perhaps the most noteworthy information in Table 2 is the substantial 
improvement in performance exhibited by all the plans comparing follow-up 
care in the first 6-month post implementation period to that in the second 6-
month period.  In Area 5, Amerigroup, HE and SW bettered their follow-up 
rates by 20% or more.  In Area 5, Amerigroup had significantly lower follow-
up rates compared to FHP (χ2=14.88, df=1, p<=.0001).  Comparing changes 
in follow up rates from the first to the second 6-month periods, the group by 
time interaction was significant (p<=.05) for all three HMOs in Area 5 
compared to FHP Area 5 indicating that the increases for the Area 5 HMOs 
from the first six months to the second six months were significantly greater 
than the increases exhibited by the PMHP in that area (which exhibited 
superior performance in the first 6-month period). 
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     Although the changes from the first to the second 6-month periods were 
less dramatic in Area 7, the performances of all plans improved.  During the 
second post implementation period all the plans in area 5 were well above the 
50th percentile for Medicaid Plan performance (55%).  Two of the four plans 
in Area 7 were above this mark.  The FHP in Area 7 performed significantly 
better than the average of all the plans, providing follow-up care to over 70% 
of hospital discharges.  In Area 7, Amerigroup also had significantly lower 
follow-up rates compared to FHP (χ2=6.92, df=1, p<=.01).  The overall 
effect of time period was significant (χ2=7.6, df=1, p<=.01) in the first 6-
month period. However, there was no group by time interactions, indicating 
that in Area 7 all groups were comparable to the PMHP in the increase in 
follow-up rates from the first six month to the second six month period. 
 
     Table 3 presents 30-day follow-up information for all the plans serving 
areas 2, 3 and 11.  Due to later managed care implementation dates, follow up 
data are available for these plans for only one 6-month post implementation 
period.  To assess group differences, we conducted a logistic regression using 
PROC GENMOD for each area, using the PMHP group in each area as a 
reference group.  In Area 11, the PH Trust was the reference group. 
Healthease in Area 11 was eliminated from the statistical analysis due to the 
low number of inpatient discharges in that plan. 
 
Table 3. Follow up care to persons discharged from inpatient care within 30 days 
Plan Area Number 
inpatient 
discharges 
% follow-up 
care 
HE 2 23 61%
Magellan 2 112 59%
HE 3 88 35%
NFBHP 3 342 58%
SW 3 35 23%
HE 11 12 50%
Magellan 11 281 63%
PH Trust 11 397 55%
SW 11 22 68%
 
     Looking at Table 3 several things are apparent.  First, the number of 
discharges generated by some of the plans are probably too few to provide 
reliable estimates of plan performance (HE in areas 2 and 11 and SW in area 
11).  Second, unlike the performances of the plans in areas 5 and 7 during the 
first 6 month implementation periods, only two of the nine plans in areas 2, 3 
and 11 were below the 50th percentile of Medicaid plan performance. Third, 
although the numbers of hospital discharges were relatively small (HE=88) 
(SW=35) in area 3, the performances of these plans were well below the 50th 
percentile for Medicaid HMO’s.  The logistic regression indicated a 
statistically significant lower probability of follow-up services for Staywell 
(χ2=13.54, df=1, p<=.001) and Healthease (χ2=13.92, df=1, p<=.001) 
compared to NFBHP.  Fourth, with reasonably large numbers of hospital  
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 discharges, , the performances of Magellan in areas 2 and 11 appeared to be 
well above the 50th percentile.  In Area 11, Magellan had a statistically 
significant greater probability of follow-up care (χ2=5.25, df=1, p<=.05) 
compared to the Public Health Trust. 
 
     Data related to the provision of post hospital discharge follow-up care 
within 3-6 months of discharge for the plans serving areas 5 and 7 are 
presented in Table 4.  To allow as long a follow-up period as possible, only 
the first inpatient stay for each person was used.  Re-admissions to inpatient, 
emergency, or other deep-end services were assessed in a separate analysis.  
We employed the same statistical techniques in the 90-180 day follow-up 
analyses that we used in the 30 day follow-up analyses.  In Area 5, Healthease 
was dropped from the statistical analysis due to a low number of inpatient 
stays. 
 
Table 4. Provision of ambulatory care 3-6 month after hospital discharge 
 Area 5 Area 7 
 N 1st 6 
mont
hs 
N 2nd 6 
months
N 1st 6 
months 
N 2nd 6 
months 
Amerigr
oup 
45 67% 60 73% 48 60% 44 75%
FHP 130 81% 115 84% 133 75% 108 79%
HE 21 71% 18 83% 56 57% 43 67%
SW 29 69% 31 84% 73 77% 66 76%
 
     Not surprisingly, the percentages of enrollees receiving post inpatient 
discharge follow-up care are greater for the 3-6 month period than for the 30 
day period.  In area 5, the performances of all the plans improved in the 
second 6 month period compared to the first. With the exception of 
Amerigroup all plans were over 80. 
 
     There were no statistically significant differences in the Area 5 analysis, 
although the difference between Amerigroup and FHP neared statistical 
significance (χ2=3.68, df=1, p<=.10) 
 
     In the first 6-month period, the performances of all the plans in area 7 
were lower than their area 5 counterparts.  Particularly problematic was HE 
which provided post discharge outpatient services to only 57% of its 
enrollees.  As in area 5, the performance of the plans in area 7 improved in 
the second 6-month period.  Particularly noteworthy were the positive 
changes in the performance of Amerigroup and HE which improved 15% 
and 10% respectively.  In this period, the performances of three of the four 
plans serving area 7 were well below those of their counterparts in area 5.  
Amerigroup’s performance was slightly better in area 7 than in area 5 in the 
second 6-month period. There were no statistically significant time period or 
group by time period interactions in Area 7.  Overall, Healthease was 
significantly lower than FHP in percentage of inpatient stays that were 
followed by ambulatory care (χ2=5.25, df=1, p<=.05).  
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 Table 5. Provision of ambulatory care in 3-6 months after hospital discharge 
Plan Areas 2, 3 and 11 
 2 3 11
  
HE * 54% *
SW - 55% *
Magellan 64% - 76%
NFBHP - 68% -
PH Trust - - 71%
* N <10 
 
     In area 2, only Magellan had a sufficient number of hospital discharges in 
the first six months of managed care implementation to provide a reliable 
estimate of performance in delivering follow-up care to hospital discharges 
during the period from 3 to 6 months after discharge.  Its performance was 
below the performance of all the plans in area 5 and two of the four plans 
serving area 7 during their first six months of managed care implementation. 
 
     Of the plans serving areas 2, 3 and 11, the performance of HE and SW in 
area 3 are particularly problematic. Almost half of the enrollees in these plans 
did not receive ambulatory services in the 3-6 months following discharge 
from a hospital stay for the treatment of a psychiatric illness. Although in the 
statistical analyses these plans were not significantly different than the pooled 
average of the plans serving the areas, only three plans served area 3 and two 
of these appear to be outliers. 
 
     The results of the analysis of the diversity of services delivered to hospital 
discharges indicated that typically 70-85% of these individuals received only 
one or two service components rather than three, or four or more 
components during the 6-month follow up periods.  There were however a 
number of exceptions to this rule.  In area 5, 38% of discharged FHP 
enrollees in the first 6 months and 42% in the second 6 months received 
more than two outpatient components in the 3-6 months following hospital 
discharge. In area 7 the performance of Amerigroup in the first 6 month 
period was significantly better than the FHP.  Fifty percent of Amerigroup 
enrollees, compared to 26% of FHP enrollees received more than two service 
components in the 3-6 month follow up periods.  The performances of the 
other plans in area 7 were similar to the performance of FHP.  In the second 
6-month period in area 7, 36% of FHP and SW enrollees received more than 
two service components. The number of components provided by the FHP 
was significantly higher than the number provided by HE and Amerigroup. 
 
     No plans in the remaining three areas provided more than two 
components to more than 70% of its enrollees discharged from inpatient care 
during the 3-6 month follow up periods.  None of the statistical analyses in 
Areas 3 and 11 indicated significant differences in the percentages of enrollees 
receiving follow up care in these plans. 
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     The 6 month readmission rates for enrollees in areas 5 and 7 that were 
discharged during the first and second 6-month periods are presented in 
Table 6.  The “N” column represents the total number of hospital discharges 
for each of the plans during each period, and the percentage column 
represents the percentage of discharged patients that were readmitted to deep 
end services within 6 months of discharge.  The analytic strategy used for 
readmission rates was similar to the approaches used in the analyses of 30 and 
90-180 day follow up rates. 
 
Table 6. Readmission rates within 6 months of hospital discharge Area 5 and Area 7 
 1st 6 months 2nd 6 months 1st 6 months 2nd 6 months
 N (%) N (%) N (%) N  (%)
FHP 130  (13) 115  (18) 133  (19) 108  (12)
HE 21  (19) 18  (22) 56  (13) 43  (19)
SW 29  (14) 31  (19) 73  (22) 66  (17)
Amer 45  (7) 60  (18) 48  (15) 44  (32)
 
     We can see in Table 6 that readmission rates ranged from 7% to 19% in 
area 5 in the first 6-month period.  Surprisingly these rates increased for all 
plans in the second six month period with all the plans clustering around 
20%.  None of the comparisons in the Area 5 analysis were statistically 
significant.  Readmission rates in the first 6-month period in area 7 were 
generally higher than in area 5.  However, in the second 6-month period the 
plans in area 7 had lower readmission rates than their area 5 counterparts.  
The one exception was for Amerigroup discharged enrollees.  In the second 
6-month period, almost one-third of these individuals were readmitted with 6 
months of discharge compared to 18% of Amerigroup discharged enrollees in 
area 5.  For Amerigroup, the group by time period interaction was significant 
indicating that the change was significantly greater than the change for FHP 
(χ2=5.74, df=1, p<=.05) (+17 vs. -7) 
 
     Readmission data for areas 2, 3 and 11 are presented in Table 7.  Numbers 
of hospital discharges and readmission rates are presented for all the plans 
serving each of the areas.  Because of later managed care implementation 
dates readmission rates are available for only one 6-month period. 
 
Table 7. Readmission rates within 6 months of hospital discharge  Areas 2, 3 and 7 
 2 3 11 
 N  (%) N  % N  %
Magellan 55  (13) -  - 120  (33)
HE 9  (11) 39  (15) 8  (25)
SW -  - 22  (18) 13  (15)
NFBHP -  - 148  (12) -  - 
PH Trust 144  (33)
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     First 6-month readmission rates for the plans in areas 2 and 3 were 
consistent with those observed for areas 5 and 7 during the same periods. 
Rates ranged from a low of 11% to a high of 18%.  Readmission rates for 
three of the four plans serving area 11 were considerably higher than those 
serving either areas 5 or 7.  One third of Magellan and PH Trust discharges 
were readmitted within 6 months.  Although HE had only eight hospital 
discharges, two of them were readmitted within 6 months. None of the 
statistical comparisons in Areas 3 or 11 reached statistical significance. 
Summary Quality of Care 
     Providing follow-up ambulatory services to patients discharged from 
hospital care is a basic indicator of quality of care for managed care plans.  In 
the first six months following managed care implementation, six out of eight 
of the plans serving areas 5 and 7 were below the 50% percentile of Medicaid 
HMO plans reporting on this HEDIS measure.  None of the plans 
approached the 75th percentile of 71% follow-up care within 30 days.  
Although there was consistent, and in some cases dramatic improvement 
during the second six month post implementation period, two of the plans 
remained below the 50th percentile and only 3 of 8 reached the 75th percentile 
of Medicaid HMO’s reporting on this HEDIS measure.  Clearly there is 
room for continued improvement in providing short term follow-up care to 
hospital discharges. 
     Performance was somewhat better during the first 6 month periods 
among the plans serving areas 2, 3 and 11 with sufficient numbers of hospital 
discharges. All but one plan was at or above the 50th percentile.  No plan 
approached the 75th percentile although in view of the improvements in 
performance observed in areas 5 and 7 in the second six month managed 
care period, there is reason to hope most of the plans will move close to or 
exceed the 75th percentile in the second six months. 
     Not surprisingly, larger percentages of patients discharged from hospital 
care received outpatient services in the 3-6 month periods following 
discharge. However, plan performance was not uniform. Amerigroup in both 
areas 5 and 7 and HE in area 7 reached less than 70% of their discharged 
enrollees in the first 6-month follow up period. As was the case with 30-day 
follow up rates, the performances of plans generally improved in the second 
6-month period following managed care implementation. 
     The rate of provision of follow up outpatient care the 3-6 month period 
after hospital discharge for the plans serving areas 2 and 3  was generally 
lower than the rates for the plans serving area 5. Area 11 rates were more 
consistent with those observed in the first 6-month follow up periods in 
areas 5. 
     Generally, 15-20% of patients discharged from inpatient care were 
readmitted to deep end services during the 3-6 month follow up periods. 
Comparing performance in the first 6-month post implementation period to 
the second for areas 5 and 7, we did not observe consistent improvements.  
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In fact, the performance of Amerigroup deteriorated notably from the first to 
the second period. In the later managed care implementation areas, the 
performance of Magellan and the PH Trust in area 11 were particularly 
problematic. One third of enrollees discharged from hospital care during the 
first six months of managed care implementation were readmitted to deep end 
services in the 3-6 months following discharge. 
Outcomes Analyses 
     Consistent with previous evaluations, we use rates of Baker Act (BA) 
evaluations and arrests as the primary measures in the evaluation of outcomes.  
Rates of Baker Act evaluations and arrests per 100 enrollees with an SMI and 
an SED are calculated for enrollees in the plans for the six months before and 
six months after each plan assumed responsibility for the behavioral health 
care of its enrollees. Only enrollees with a full six months of eligibility in the 
baseline period, and in the six and twelve month periods after the 
implementation of managed behavioral health care, are included in these 
analyses.  The rates in the baseline and post-implementation periods are 
compared for each of the populations for each plan in Areas 2, 3, 5, 7 and 11.  
     Baker Act evaluations and arrests are relatively rare events within 6-month 
time intervals. Therefore, even changes that appear to be noteworthy 
sometimes do not reach statistical significance.  We will first present the 
results of the statistical analyses. We will then describe changes and compare 
rates in some instances where the differences between plans were not 
statistically significant, but where ongoing activity should be monitored. In 
these analyses we report the number of individuals in the analysis, the number 
of individuals with a negative outcome, and the number of negative outcomes 
associated with the baseline and post-implementation periods.  This allows the 
Agency to identify changes that may warrant closer scrutiny of the plans or 
follow-up actions.  For example, if a plan had 150 adults with a serious mental 
illness and their rates of Baker Act evaluations tripled from the 6-month 
baseline to the 6-month post implementation periods, the Agency may seek 
more information even if the change does not reach statistical significance.   
     The statistical technique used for these analyses is general linear modeling 
(GLM), a form of regression analysis that, in this case, is used to test the null 
hypothesis that the outcomes of enrollees of the various plans did not change 
from the 6-month baseline to the six and twelve months post implementation 
periods. In addition, the technique tests the null hypothesis that the plans did 
not change differently pre to post managed care implementation. In statistical 
terms, the hypotheses are that there is no main effect of time and that the 
plan by time interaction = 0. Differential change could have occurred, for 
example, if the rates of Bake Act evaluations for enrollees in one plan tripled 
from the baseline to the post period while those of the other plans remained 
the same or actually declined.  Similarly, the outcomes of all plans could 
improve or deteriorate, but some much more dramatically than others.  
Outcomes are reported for children with an SED and adults with an SMI in 
each of the areas. 
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Children with a SED 
 
     In this year’s evaluation there were few significant changes in outcomes 
pre to post managed care implementation for children with an SED. Table 8 
presents Baker Act evaluation data for area 3 which was the only area where 
there were notable changes in the outcomes of children with a SED from the 
pre to the post period.  
 
Table 8. Rates of Baker Act Evaluations in Six Months per 100 enrollee months Pre 
and PosManaged Care (Area 3) 
Plan 6 months pre 6 months post
HE 1.78 1.39
NEBHP 2.99 2.14
Stay well 7.14 6.04
United 7.44 2.70
 
     Several observations related to Baker Act rates in area 3 are worth 
mentioning.  First, as previously mentioned, these events are relatively rare in 
all populations.  They are especially rare for children under 18 years of age. 
Second, in area 3 there was a significant main effect of time indicating that, 
overall, the transition to managed care resulted in significantly lower rates of 
Baker Act initiations per 100 enrollees for children with an SED (P<.05).  
Third, the rates of Baker Act initiations for SW in area 3 in both the pre and 
post periods were more than twice those of NFBHP and HE. United had a 
comparable rate in baseline, but post implementation, the rate had stabilized 
to the area 3 rate seen in HE and NFBHP.  It would appear that SW and 
United enrollees with an SED were less stable and more prone to emergency 
psychiatric evaluation than the other two plans.  There were not significant 
plan by time interactions, meaning the change in rates pre to post periods 
were not significantly different for the plans serving area 3.   
     Although there were few significant changes in outcomes for enrollees 
with a SED served by the different plans in areas 2, 5, 7 and 11, there were 
some notable differences between areas. Table 9 presents the arrest and Baker 
Act rates for the 6-month periods immediately following managed care 
implementation in each of these areas. 
 
Table 9. Arrest and Baker Act Rates Children with a SED (First Post Period) 
 # of  SED 
enrollees 
(eligible 6 
months) 
# of 
arrests 
Arrest Rates 
per 100 
enrollees 
# of Baker 
Acts 
Baker Act 
Rates per 
100 
enrollees 
Area 5  2905 81 2.8 136 4.7
Area 7 5641 147 2.6 122 2.2
Area 2 2119 44 2.1 45 2.1
Area 3 3738 184 4.9 84 2.2
Area 11 7500 228 3.0 94 1.2
Total 21903 684 3.1 481 2.2
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Table 10. Arrests and Baker Act Evaluations SMI Adults 
 # of  
SED 
enrollees 
(eligible 
6 
months)
# of 
arrests 
Arrest 
Rates per 
100 
enrollees 
# of Baker 
Acts 
Baker Act 
Rates per 
100 
enrollees 
# of  SED 
enrollees 
(eligible 6 
months) 
    
Area 3 130 1706 7.6 166 1706 9.7
Area 2 75 791 9.5 96 791 12.1
Area 
11 
387 7004 5.5 572 7004 8.2
Area 5 139 1597 8.7 180 1597 11.3
Area 7 177 2173 8.1 224 2173 10.3
Total 769 13271 5.8 1238 13271 9.3
 
 
 
     It can be seen in Table 9 that the Baker Act evaluation rates for area 5 
were more than twice those of the other areas. in the 6-month period. 
Although not shown in Table 6, this was also true in both the pre managed 
care periods and therefore, does not appear to be related to the 
implementation of managed behavioral health care. No other main effects of 
time and no plan by time interactions were observed in any of the remaining 
areas.   
     We also observed few significant changes in arrest rates for children with 
an SED pre to post managed care implementation.  There was a significant 
main effect of time in two areas.  Overall, arrest rates declined pre to post 
managed care in areas 5 and increased in area 7 (P< .0001).  In area 3, arrest 
rates were 1.5 to 2 times the rates in the other areas in both the pre and post 
periods. 
     Somewhat surprisingly, arrest rates for children with an SED were higher 
than rates of Baker Act evaluations in the post implementation periods in 
three of the five areas.  We can see in Table 9 that this was the case in areas 3, 
7 and 11.  In areas 3 and 11, arrest rates are more than twice the rates of 
Baker Act evaluations.  These data would seem to suggest that many children 
with an SED are penetrating the criminal justice rather than the mental health 
treatment system. 
 
Adults with an SMI 
 
     Rates of arrests and Baker Act evaluations for adults with a SMI are 
presented in Table 10. Plan specific data are not presented because no main 
effects of time, plan or plan by time interactions were found for adults with an 
SMI in any area.  
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     We can see in Table 10, that unlike children with an SED, Baker Act rates 
are higher than arrest rates in all areas for adults with an SMI.  Not 
surprisingly, arrest rates and Baker Act rates/100 enrollee months are much 
higher for adults with an SMI than for children with a SED. (See Table 9) 
 
     Although the numbers of evaluations are small, and the changes are not 
statistically significant, two plan specific situations may warrant ongoing 
monitoring.  The first is in area 3 where the rates of Baker Act evaluations for 
SW enrollees increased from 8.4/100 in the pre period to 15.2 in the post 
implementation period.  In the pre period there were 7 Baker Acts for 83 
months of enrollment; in the post period there were 14 evaluations for 92 
months of enrollment.  Similarly, in area 11, rates of Baker Act evaluations for 
HE enrollees increased from 2.5 to 12.1/100 enrollee months.  There were 
two evaluations for 81 enrollee months in the pre period and 11 evaluations 
for 91 enrollee months in the post period. 
 
Summary Outcomes 
 
     This year’s outcomes analysis does not indicate significant differences in 
the rates of Baker Act evaluations and arrests pre to post managed care 
implementation.  Although the performances of SW in area 3 and HE in area 
11 with adults with an SMI warrant ongoing monitoring, we cannot conclude 
that performance deteriorated for enrollees in these plans.  Since the numbers 
of events are relatively small, the addition or subtraction of a single event 
would significantly change the rates. 
     It is perplexing that arrest rates exceed Baker Act rates for children with an 
SED for three of the five areas and are identical in a fourth.  This suggests 
there may be potential to divert children from the criminal justice to the 
mental health system.  The situation in area 3 is particularly noteworthy.  
While there was an overall decrease in the rates of Baker Act evaluations as 
managed care was implemented, arrest rates for children with an SED were 
more than twice the pooled average of all the areas.  On the other hand, in 
area 5, while the arrest rate was less than the pooled average of all the areas in 
the post period, the rate of Baker Act evaluations was more than twice that of 
all the areas and two times the pooled average for the five areas.  It is difficult 
to know what to make of these observations using only administrative data.  
However, a closer look at both situations is probably warranted. 
 
Conclusions 
 
     The implementation of managed behavioral changed both the kinds of 
services delivered to enrollees with a SED and an SMI and their relative 
frequency. Ambulatory care tended to shift toward more traditional office 
visits and away from community mental health services and supports. While it 
is too early to make judgments about the impacts of this shift, the increases in 
the use of inpatient psychiatric care that occurred in the post implementation  
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period with a number of plans may point to future problems. 
 
     The change in the mix of ambulatory services delivered to children with a 
SED and adults with a SMI did not negatively affect short term outcomes. 
However, Baker Act evaluations and arrests are rare events even in this 
population. The conditions of enrollees with serious problems may have 
suffered without producing increases in these relatively crude measures.  
 
     The performance of many of the plans in providing follow up care to 
enrollees discharged from inpatient care within 30 days was inadequate at least 
during the first six month post implementation period. The significant 
improvement observed in the second six month period in areas 5 and 7 may 
indicate this is a short term problem associated with the transition to managed 
care.  
 
     Readmission rates during the 3-6 months following hospital discharge 
actually increased in areas 5 and 7 from the first six month period to the 
second. These rates were especially high for Amerigroup in area 7. 
Readmission rates for Magellan and the PH Trust in area 11 were particularly 
high in the first post implementation period and require careful monitoring 
going forward. 
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Appendices 
 
Appendix 1. Definitions. 
 
Enrollees: 
1. All Medicaid enrollees who met the following conditions for the time 
periods where all the numbered conditions were true during the 
baseline and post-implementation periods: 
2. Age between 1 and 64 years. 
3. Be in TANF, SSI, or SOBRA.  We have adopted the following 
algorithm for determining eligibility program based on eligibility code 
that remains constant across all analyses: 
a. TANF='MA I', 'MA R', 'MA U', 'ME C‘, 'ME I', 'ME T', 'MN', 
'MO A', 'MO D', 'MO P‘, 'MO S', 'MO T‘, 'MO U', 'MO Y', 
'MP C', ‘MP N‘, 'MP U‘ 
b. SSI='MI A', 'MS', 'MT A', 'MT C', 'MT D', 'MT S', 'MT W‘ 
c. SOBRA='MM C', 'MM I‘ while under the age of 21. 
4. Met any of the following enrollment criteria: 
a. Were assigned to an HMO in one of the counties in Area 2, 3, 
5, 7 or 11 based on the Medicaid HMO enrollment file OR 
b. Period was baseline and were enrolled in Medipass in Area 2, 
3, 5, 7 or 11 counties based on the Medicaid Medipass 
enrollment file OR 
c. Period was post-implementation and were enrolled in a PMHP 
operating in Area 2, 3, 5, 7 or 11 based on the Medicaid 
PMHP enrollment file. 
Due to an exceptionally low count of capitation payments for April 2006, 
which completely eliminated that month from some of the PMHPs studied, 
we could not verify enrollment in a plan using cap payments as we had done 
in past years.   
 
Diagnostic Groups for Analyses: 
 
1. Bipolar Disorder (ICD-9 diagnosis in range from 296.4-296.99 or 296-
296.19) 
2. Schizophrenia and Psychoses (ICD-9 diagnosis in range from 295-
295.99 or 297-298.99) 
3. Major Depression (ICD-9 diagnosis in range from 296.2-296.39) 
4. Hyperkinetic Disorder (ICD-9 diagnosis in range from 314-314.99) 
5. Conduct Disorder ICD-9 diagnosis in range from 312-312.99) 
6. Anxiety Disorder (ICD-9 diagnosis in range from 300-300.99) 
7. Depressive Disorder (ICD-9 diagnosis in range from 311-311.99) 
8. Childhood Emotional Disturbance (ICD-9 diagnosis in range from 
313-313.99) 
9. Specific Developmental Delays ((ICD-9 diagnosis in range from 315-
315.99). 
   26 ? Louis de la Parte Florida Mental Health Institute June 2008 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Definition of Child SED 
 
1. Meet any of Definitions A-C and be under the age of 21: (Is A-C 
clear?) 
 
2. Be classified as SED or PSMI in the IDS admissions file for any 
admission from July 1 1995-June 30 20031 while under the age of 18 
and be Medicaid eligible at some point during the time period for the 
study. 
3. Not meet Condition A but have at least 2 claims on different days in 
one of the following diagnostic categories: 
a. Bipolar Disorder (as above) 
b. Schizophrenic Disorders (as above) 
c. Major Depressive Disorder (as above) 
d. Personality Disorder (ICD-9 diagnosis in range from 301-
301.99). 
4. Not meet conditions A or B but have at least 2 claims on different 
days in at least 2 of the following 7 conditions (there must be at least 2 
claims for each condition met): 
a. ADHD (as above) 
b. Conduct/Oppositional Disorder (as above or 313.81) 
c. Anxiety Disorder (ICD-9 diagnosis in range from 300-300.99, 
or 308-308.99, or 313-313.99) or in (309.81,309.89,309.21) but 
not in   (300.40,300.15,300.16,300.19) 
d. Depressive Disorder (ICD-9 diagnosis in range from 311-
311.99) or in ('300.40', '301.13') 
e. Anti-Psychotic medication (total claims must total at least a 
60-day supply of medication, generic names for 
pharmaceuticals include: ARIPIPRAZOLE, CLOZAPINE, 
OLANZAPINE, QUETIAPINE FUMARATE, 
RISPERIDONE, ZIPRASIDONE HCL, 
CHLORPROMAZINE HCL, FLUPHENAZINE 
DECANOATE, FLUPHENAZINE HCL, 
HALOPERIDOL, HALOPERIDOL DECANOATE, 
HALOPERIDOL LACTATE, LOXAPINE SUCCINATE, 
MESORIDAZINE BESYLATE, MOLINDONE HCL, 
PERPHENAZINE, THIORIDAZINE HCL, 
THIOTHIXENE, TRIFLUOPERAZINE HCL). 
f. Anti-Depressant medication (total claims must total at least a 
60-day supply of medication, generic names for 
pharmaceuticals include: CITALOPRAM 
HYDROBROMIDE, FLUOXETINE HCL, 
FLUVOXAMINE MALEATE, PAROXETINE HCL, 
SERTRALINE HCL, BUPROPION HCL, MIRTAZAPINE, 
NEFAZODONE HCL, TRAZODONE HCL, 
VENLAFAXINE HCL).  
g. Mood Stabilizers (total claims must total at least a 60-day 
supply of medication, generic names for pharmaceuticals  
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2 Date range for current IDS file. 
include: CARBAMAZEPINE, CLONAZEPAM,
DIVALPROEX SODIUM, GABAPENTIN, 
LAMOTRIGINE, LITHIUM CARBONATE, LITHIUM 
CITRATE, OXCARBAZEPINE, TOPIRAMATE, 
VALPROATE SODIUM, VALPROIC ACID). 
 
Definition of Adult SMI 
 
Have at least 1 claim in one of the following diagnostic or pharmacy use 
categories: 
a. Bipolar Disorder (ICD-9 diagnosis in range from 296.4-
296.99' or 296-296.19) 
b. Schizophrenic Disorders (ICD-9 diagnosis in range from 295-
295.99 or 297-298.99) 
c. Major Depressive Disorder (ICD-9 diagnosis in range from 
296-296.39) 
d. Anti-Psychotic medication (total claims must total at least a 
60-day supply of medication, generic names for 
pharmaceuticals include: ARIPIPRAZOLE, CLOZAPINE, 
OLANZAPINE, QUETIAPINE FUMARATE, 
RISPERIDONE, ZIPRASIDONE HCL, 
CHLORPROMAZINE HCL, FLUPHENAZINE 
DECANOATE, FLUPHENAZINE HCL, 
HALOPERIDOL, HALOPERIDOL DECANOATE, 
HALOPERIDOL LACTATE, LOXAPINE SUCCINATE, 
MESORIDAZINE BESYLATE, MOLINDONE HCL, 
PERPHENAZINE, THIORIDAZINE HCL, 
THIOTHIXENE, TRIFLUOPERAZINE HCL)1. 
 
Service Definitions 
 
All Medicaid claims that met one of the following criteria were included in the 
analysis as long as the first date of service was in the eligibility period as 
determined above. 
General requirements for MH definition: 
 
1. Any encounter reported by Florida Health Partners, Amerigroup, 
Healthease, and Staywell to AHCA 
2. Any Specialty Mental Health procedure code as defined by the CPT 
manual or the AHCA Community Mental Health or Targeted Case 
Management Handbooks OR 
 
3. Has a diagnosis between 290. And 314.99 OR 
 
4. Service provided by MH practitioner OR 
 
5. Has an MH appropriations code.
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Carve-Out Mental Health Services4 
 
1. Level 1: Inpatient MH with Carve-Out Diagnoses1 
a. Provider Type is Hospital (only AHCA FFS claims have this 
information). 
b. Type of bill is Inpatient Hospital for AHCA FFS claims or 
Service Type=Inpatient for Managed Care Encounters 
c. UB92 has a Revenue Codes of 114, 124, 134, 144, 154, or 204.  
If encounters are missing revenue codes but have a service 
type of Inpatient, the encounters are included. 
d. For managed care, additional procedure codes for CSU and 
Residential services are included here. 
e. Primary Diagnosis is in Carve Out range (information 
available in all datasets and all claims must meet this 
condition) 
2. Level 1: Outpatient Hospital with Carve-Out Diagnoses  
a. Provider Type is Hospital (only AHCA FFS claims have this 
information) 
b. Type of bill is Outpatient Hospital for AHCA FFS or Service 
Type=Outpatient Hospital for managed care encounters 
c. UB92 has Revenue Center codes of 450, 513, 901, 914, or 918 
or both revenue code and procedure code is missing for 
managed care encounters. 
d. Primary Diagnosis is in Carve Out range (information 
available in all datasets and all claims must meet this 
condition) 
3. Level 1: Psychiatric Physician’s Specialty Services  
a. Provider Type is Physician for AHCA FFS claims or Service 
Type is Physician for managed care encounters 
b. Provider Specialty is Psychiatry, Child Psychiatry, and 
Psychoanalysis.  Only AHCA FFS claims have this 
information so this information is not required for managed 
care encounters 
c. For managed care encounters, psychiatric or physician CPT-
procedure codes also indicate psychiatrist claims 
d. Primary Diagnosis is in Carve Out range (information 
available in all datasets and all claims must meet this 
condition) OR
3 Condition D was not employed for the HMO groups because we did not have 
pharmacy data for the baseline and July 1, 2005-September 20, 2005 time periods.  
We felt that including recipients based on pharmacy in one HMO plan, but not in 
others would lead to unfair comparisons because those persons who did not have 
SMI diagnoses were less likely to have service penetration than those who did have 
diagnoses from the service files.  
4 Service must meet all of the qualifications under each level. 
5 Carve-Out diagnoses are for those people with claims with the following primary 
diagnoses (ICD-9): 290-290.43; 293-298.9; 300-301.9; 302.7; 306.51-312.4; 312.81-
314.9; 315.3; 315.31; 315.5; 315.8; 315.9.  
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4. Advance Nurse Practitioner Services  
a. Provider Type is Advanced Nurse Practitioner for AHCA FFS 
or Service Type is Advanced Nurse Practitioner for managed 
care encounters 
b. Provider Specialty is Clinical Nurse Specialist for AHCA FFS 
claims only 
c. Diagnosis is in range of section 1d above 
5. Level 2: Community Mental Health Services 
a. Provider Type is Community Mental Health Center for 
AHCA FFS claims. Although managed care claims have a 
service type of Community Mental Health Center, this 
information was considered redundant as many CMH codes 
were given other service types.  For consistency, service type 
was ignored in the presence of the following procedure codes. 
b. Procedure codes indicates one of the following services (code 
7/1/03-10/15/03; code 10/16/03-10/1/04; code 10/1/04 
until present if applicable) :  
i) Basic Outpatient: Office and Outpatient Visits (W1037 or 
W1038; H0002), Psychiatric Services (W1050; H2010; 
T1015, H2010HO, H2010HQ, H2010HE, H2010HF, 
T1023HE, T1023 HF), Clinic Visit (W1070; H0046HE; 
H0046, T1015HE, T1015HF), Individual Behavioral 
Therapy (W1074; H0004; H2019HR), Group Behavioral 
Therapy (W1075; H0004HQ; H2019HQ). 
ii) Intensive Outpatient: Mental Health Day Treatment including 
any clubhouse or supported employment (W1023; H2012; 
H2012), Rehabilitation Day Treatment (W1064; H2017), 
Intensive Therapeutic On-Site Services (W1071; H2021; 
H2019HO), Home and Community Based Rehabilitative 
Services (W1072;H2021HM; H2019HN), 
iii) Assessment: Bio-psycho-social Evaluation 
(W1027;H0031HN; H0031HN), Psychiatric Evaluation 
(W1030; H2010HP; H2000 HP), Interpretation of Results 
of Psychiatric Exam (W1031; H2010HN; H2000), Limited 
Functional Assessment (W1039; H0031HM; H0031), In-
depth Mental Health Assessment (W1048; H0031HO; 
H0031HO), Psychological Testing (W1073; H0031; 
H2019) 
iv) Treatment Planning: Treatment Plan Development (W1067 
or W1068; H0032; H0032), Treatment Plan Review 
(W1069; H0032TS; H0032TS) 
v) Other CMH: Basic Living Skills Training (W1044; H2014; 
H2017), Social Rehabilitation and Counseling (W1046; 
H2014; H2017). 
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c. Managed Care claims that have indicated a behavioral health 
service do not require the modifier in post-HIPAA 
implementation data.  (Applicable to only managed care claims 
as use of the modifier was inconsistent). 
d. Primary Diagnosis is in Carve Out range (information 
available in all datasets and all claims must meet this 
condition) 
e. Level 2: Targeted and Intensive Targeted Case Management 
f. Provider Type is Case Management Agency (only AHCA FFS 
claims have this information). 
g. Procedure Code indicates Targeted Case Management for 
Chronically Mentally Ill Children (W9891; T1017HA; 
T1017HA) or Adults (W9892; T1017; T1017), or Intensive 
Case Management (W9899; T1017HK; T1017HK). For 
managed care following the date of HIPAA implementation, the code 
T1017 without any modifier is assumed to be Targeted Case 
Management.  For PMHP, Specialized Case Management services 
(F0001 or F0002 or F0054, T1017HE, H0043, T1017HH) are 
included in Carve-Out Case Management. 
h. Level 2:  approved services- other services listed by PMHP 
providers assumed to be in Carve-Out  
i. Psycho-educational Services for Client and Family 
(F0030 or F0031 or F9805, H2027). 
ii. Other procedure codes for special services as defined 
by PMHP provider. 
iii. Procedure codes listed in the approved codes but not 
in the above with carve-out diagnoses were considered 
in this category. 
i. Mental Health Services Outside of Carve-Out6 
j. Level 3: Other Inpatient Hospital Claims or Encounters. 
1. Provider Type is Hospital for AHCA FFS 
claims or Service Type is Inpatient or CSU or 
managed care claims 
2. Type of bill is Inpatient Hospital  
3. UB92 has a Revenue Codes of 114, 124, 134, 
144, 154, 204 with a secondary diagnosis in 
MH range (290-314) or a primary diagnosis in 
MH range but not in Carve Out range OR. 
4. UB92 has other inpatient hospital bed day 
revenue codes with any MH diagnosis. 
k. Level 2:  approved services- other services listed by PMHP 
providers assumed to be in Carve-Out  
i. Psycho-educational Services for Client and Family 
(F0030 or F0031 or F9805, H2027). 
ii. Other procedure codes for special services as defined 
by PMHP provider. 
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iii. Procedure codes listed in the approved codes but not 
in the above with carve-out diagnoses were considered 
in this category. 
6. Mental Health Services Outside of Carve-Out1 
7. Level 3: Other Inpatient Hospital Claims or Encounters. 
a. Provider Type is Hospital for AHCA FFS claims or Service 
Type is Inpatient or CSU or managed care claims 
b. Type of bill is Inpatient Hospital  
c. UB92 has a Revenue Codes of 114, 124, 134, 144, 154, 204 
with a secondary diagnosis in MH range (290-314) or a 
primary diagnosis in MH range but not in Carve Out range 
OR. 
d. UB92 has other inpatient hospital bed day revenue codes with 
any MH diagnosis. 
8. Level 3: Other Outpatient Hospital Claims or Encounters  
a. Provider Type is Hospital for AHCA FFS claims or Service 
Type is Inpatient or CSU or managed care claims 
b. Type of bill is Inpatient Hospital  
c. UB92 has a Revenue Codes of 114, 124, 134, 144, 154, 204 
with a secondary diagnosis in MH range (290-314) or a 
primary diagnosis in MH range but not in Carve Out range 
OR. 
d. UB92 has other inpatient hospital bed day revenue codes with 
any MH diagnosis. 
9. Level 3: Other Outpatient Hospital Claims or Encounters  
a. Provider Type is Hospital for AHCA FFS claims or Service 
Type is Outpatient Hospital for managed care claims 
b. Type of bill is Outpatient Hospital 
c. UB92 has Revenue Center codes of 450, 513, 901, 914, or 918 
d. Primary Diagnosis is in MH range but not in Carve-Out range 
or secondary diagnosis in MH range. 
10. Level 3: Psychiatric Services  
a. Provider Type is Physician 
b. Provider Specialty is Psychiatry, Child Psychiatry, and 
Psychoanalysis 
c. Primary Diagnosis is in MH range but not in Carve-Out range 
or secondary diagnosis in MH range. 
11. Level 3: Non-psychiatric physician or nursing services for behavioral 
health  
a. Provider Type is Physician or Advanced Nurse Practitioner 
b. Provider Specialty is not Psychiatry, Child Psychiatry, and 
Psychoanalysis. 
c. Primary or Secondary diagnosis in the MH range. 
6 These services are not reimbursable under the Prepaid Behavioral Health Plan as currently 
defined.  They are included to adequately describe all services provided for behavioral health 
problems.  These services are not analyzed for the HMO plans as these are not required to be 
reported in the encounter system.  However these services were used, when available for 
diagnostic and SED/SMI classifications. 
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12. Level 3: Medical Services 
a. Any other services covered under the HMO Health Plan.  
13. Level 4: Community Mental Health Services not covered in Carve-Out 
(Note these services are only found in AHCA FFS files and if found 
in managed care file are not counted). 
a. Excluded services such as Behavioral Health Overlay (W1040 
or W1041; H2022H or H2022; H2020HA or H2020 HK), 
Comprehensive Assessment (W1059; H0031HA; H0031HA), 
Specialized Therapeutic Group Care (W1080; H0019; H0019), 
and Specialized Therapeutic Foster Care (W1058-
W1061;S5145, S5145HE, S5145HE;S5145, S5145HE, 
S5145HE) 
b. Non-excluded services with a MH primary diagnosis in the 
Carve Out range or any MH secondary diagnosis 
14.  Level 4: Other services for behavioral health  
a. Primary diagnosis is in the MH range 
b. Provider and service type not listed above 
c. Service is commonly found in AHCA records for HMO 
clients. 
Service Penetration 
 
Recipient has penetrated a service type if they have received at least one 
service in a six-month time period1, while eligible within plan, eligibility type, 
and age group.  The numerator is the number of eligible months for recipients 
that penetrated service category while eligible in plan eligibility type and age 
group.  The denominator is the number of eligible months for all eligible 
recipients within a plan, eligibility type, gender, race, and age group. 
 
Service Frequency 
 
For those persons who have penetrated a given service, frequency is the 
number of days of service that a person has received that service category per 
month of eligibility. 
 
Enrollment: Outcomes Analysis 
 
Meets all enrollment qualifications as outlined in enrollment definition AND 
has six months eligibility in time period. 
 
Arrest 
1. FDLE arrest record has at least an 80% score for SSN matched to 
Enrollee’s SSN as listed in AHCA Medicaid Enrollment files on 
1/08/08. 
2. Any other FDLE arrest record on the same day for the same person is 
considered the same arrest. 
3. Met SED or SMI definition and were eligible the entire 6 months of 
the period studied.
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Baker Act 
 
1. Any Baker Act initiation record that contained an SSN that matched 
enrollee’s SSN as shown in AHCA Medicaid records on 1/08/08. 
2. PSRDC defines any Baker Act initiation that occurs within 3 days of 
another initiation for the same SSN as a duplicate initiation.  We 
eliminated all duplicate initiations. 
3. In addition, we eliminated any Baker Act initiation not previously 
eliminated that had the same date of initiation on the record for the 
same enrollee.  This was primarily a check.  
 
Appendix 2: Service Penetration and Density Analyses 
 
Table 1. SED Analysis: Comparison of Inpatient Services Penetration Among 
Area 5 Plans. 
 
Source Wald
Main Effect of Time χ2= 41.26, df= 2, p=<.0001
Main Effect of Plan χ2= 13.41, df= 3, p=0.0038
Time by Plan Interaction χ2= 27.10, df= 6, p=0.0001
 
 
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Implement
ation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 5 
2.86% 2.92% 5.05% χ2= 3.20, 
df= 1, 
p=0.0737 
χ2= 9.12, 
df= 1, 
p=0.0025 
χ2= 1.25, 
df= 1, 
p=0.2628 
FHP Area 5 1.97% 5.14% 4.68%
Healthease 
Area 5 
4.95% 4.19% 3.73% χ2= 13.15, 
df= 1, 
p=0.0003 
χ2= 7.90, 
df= 1, 
p=0.0050 
χ2= 8.75, 
df= 1, 
p=0.0031 
Staywell 
Area 5 
3.83% 4.20% 3.17% χ2= 6.26, 
df= 1, 
p=0.0123 
χ2= 4.97, 
df= 1, 
p=0.0258 
χ2= 7.38, 
df= 1, 
p=0.0066 
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Table 2. SED Analysis: Comparison of Inpatient Services Penetration Among 
Area 7 Plans. 
 
Source Wald 
Main Effect of Time χ2= 11.79, df= 2, p=0.0027 
Main Effect of Plan χ2= 9.20, df= 3, p=0.0267 
Time by Plan Interaction χ2= 16.21, df= 6, p=0.0127 
 
 
 
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Implementa
tion to 2nd 
6 Months 
Compared 
to PMHP 
Amerigroup 
Area 7 
1.55% 2.44% 1.54% χ2= 0.21, 
df= 1, 
p=0.6471 
χ2= 0.02, 
df= 1, 
p=0.9004 
χ2= 1.04, 
df= 1, 
p=0.3078 
FHP Area 7 1.52% 2.60% 2.54%  
Healthease 
Area 7 
1.84% 2.83% 2.13% χ2= 0.82, 
df= 1, 
p=0.3661 
χ2= 0.18, 
df= 1, 
p=0.6757 
Χ2= 1.85, 
df= 1, 
p=0.1738 
Staywell 
Area 7 
2.62% 2.09% 1.85% Χ2= 7.30, 
df= 1, 
p=0.0069 
Χ2= 7.40, 
df= 1, 
p=0.0065 
Χ2= 11.08, 
df= 1, 
p=0.0009 
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Table 3. SED Analysis: Comparison of Inpatient Services Penetration Among 
Area 2 Plans. 
Source Wald
Main Effect of Time Χ2= 0.01, df= 1, p=0.9183
Main Effect of Plan Χ2= 0.07, df= 1, p=0.7852
Time by Plan Interaction Χ2= 0.00, df= 1, p=0.9842
 
 
Garamond
Plan 
Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Amerigroup 
Area 7 
1.89% 1.86% 1.54% χ2= 0.21, 
df= 1, 
p=0.6471 
χ2= 0.02, df= 1, 
p=0.9004 
FHP Area 7 1.81% 1.69% 2.54%  
 
 
Table 4. SED Analysis: Comparison of Inpatient Services Penetration Among 
Area 3 Plans. 
Source Wald
Main Effect of Time Χ2= 4.24, df= 1, p=0.0394
Main Effect of Plan Χ2= 2.30, df= 2, p=0.3166
Time by Plan Interaction Χ2= 0.39, df= 2, p=0.8213
 
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan Means 
Compared to PMHP 
Mean 
Change from Pre-
Implementation 
to 1st 6 Months 
Compared to 
PMHP 
Healthease 
Area 3 
2.07% 2.73% Χ2= 0.39, df= 1, 
p=0.5301 
Χ2= 0.00, df= 1, 
p=0.9768 
NFBHP Area 3 1.61% 2.14%  
Staywell Area 3 3.06% 2.82% Χ2= 4.19, df= 1, 
p=0.0407 
Χ2= 0.49, df= 1, 
p=0.4851 
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Table 5. SED Analysis: Comparison of Inpatient Services Penetration Among 
Area 11 Plans. 
 
Source Wald
Main Effect of Time Χ2= 1.05, df= 1, p=0.3050
Main Effect of Plan Χ2= 10.66, df= 3, 
p=0.0137 
Time by Plan 
Interaction 
Χ2= 15.31, df= 3, 
p=0.0016 
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means 
Compared to 
PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 11 
1.75% 0.24% Χ2= 1.71, df= 1, 
p=0.1909 
Χ2= 9.25, df= 1, 
p=0.0024 
Magellan 
Area 11 
1.22% 1.01% Χ2= 0.02, df= 1, 
p=0.8931 
Χ2= 2.44, df= 1, 
p=0.1181 
PH Trust 
Area 11 
1.38% 1.47%
Staywell 
Area 11 
0.55% 0.58% Χ2= 4.81, df= 1, 
p=0.0283 
Χ2= 0.05, df= 1, 
p=0.8226 
 
 
Table 6. SED Analysis: Comparison of Inpatient Services Density Among 
Area 5 Plans. 
 
Source Wald
Main Effect of Time Χ2= 2.59, df= 2, p=0.2740
Main Effect of Plan Χ2= 0.76, df= 3, p=0.8578
Time by Plan Interaction Χ2= 6.99, df= 6, p=0.3222
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Impleme
ntation to 
1st 6 
Months 
Compare
d to 
PMHP 
Change 
from Pre-
Implement
ation to 2nd 
6 Months 
Compared 
to PMHP 
Amerigro
up Area 5 
0.71 0.52 0.51 Χ2= 5.07, 
df= 1, 
p=0.0244 
Χ2= 22.29, 
df= 1, 
p=<.0001 
Χ2= 0.28, 
df= 1, 
p=0.5958 
FHP 
Area 5 
0.81 0.49 0.47  
Healtheas
e Area 5 
0.4 0.6 0.49 Χ2= 1.80, 
df= 1, 
p=0.1803 
Χ2= 0.99, 
df= 1, 
p=0.3194 
Χ2= 2.82, 
df= 1, 
p=0.0929 
Staywell 
Area 5 
0.47 0.46 0.65 Χ2= 0.82, 
df= 1, 
p=0.3652 
Χ2= 3.93, 
df= 1, 
p=0.0475 
Χ2= 0.92, 
df= 1, 
p=0.3375 
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Table 7. SED Analysis: Comparison of Inpatient Services Density Among 
Area 7 Plans. 
 
Source Wald
Main Effect of Time Χ2= 2.12, df= 2, p=0.3460
Main Effect of Plan Χ2= 3.43, df= 3, p=0.3303
Time by Plan Interaction Χ2= 5.84, df= 6, p=0.4410
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Implemen
tation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 7 
0.44 0.65 0.85 Χ2= 7.86, 
df= 1, 
p=0.0051 
Χ2= 5.52, 
df= 1, 
p=0.0188 
Χ2= 3.70, 
df= 1, 
p=0.0543 
FHP Area 7 0.7 0.6 0.54  
Healthease 
Area 7 
0.49 0.62 0.72 Χ2= 1.43, 
df= 1, 
p=0.2317 
Χ2= 2.52, 
df= 1, 
p=0.1123 
Χ2= 2.10, 
df= 1, 
p=0.1471 
Staywell 
Area 7 
0.48 0.6 0.62 Χ2= 2.63, 
df= 1, 
p=0.1050 
Χ2= 7.37, 
df= 1, 
p=0.0066 
Χ2= 5.47, 
df= 1, 
p=0.0193 
 
 
Table 8. SED Analysis: Comparison of Inpatient Services Density Among 
Area 2 Plans. 
 
Source Wald
Main Effect of Time Χ2= 2.03, df= 1, p=0.1538
Main Effect of Plan Χ2= 0.58, df= 1, p=0.4457
Time by Plan Interaction Χ2= 0.04, df= 1, p=0.8403
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means 
Compared to 
PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease Area 
2 
1.05 1.14 Χ2= 8.64, df= 1, 
p=0.0033 
Χ2= 2.65, df= 1, 
p=0.1037 
Magellan Area 2 0.66 1.11  
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Table 9. SED Analysis: Comparison of Inpatient Services Density Among 
Area 3 Plans. 
 
Source Wald
Main Effect of Time Χ2= 2.03, df= 1, p=0.1538
Main Effect of Plan Χ2= 0.58, df= 1, p=0.4457
Time by Plan Interaction Χ2= 0.04, df= 1, p=0.8403
 
Plan Last 6
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 2 
1.05 1.14 Χ2= 8.64, df= 1, 
p=0.0033 
Χ2= 2.65, df= 1, 
p=0.1037 
Magellan 
Area 2 
0.66 1.11
 
 
Table 10. SED Analysis: Comparison of Inpatient Services Density Among 
Area 11 Plans. 
 
Source Wald
Main Effect of Time Χ2= 0.01, df= 1, p=0.9137
Main Effect of Plan Χ2= 6.80, df= 3, p=0.0786
Time by Plan Interaction Χ2= 8.23, df= 3, p=0.0415
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 11 
1.3 0.17 Χ2= 22.64, df= 1, 
p=<.0001 
Χ2= 31.98, df= 1, 
p=<.0001 
Magellan 
Area 11 
0.63 0.95 Χ2= 32.13, df= 1, 
p=<.0001 
Χ2= 1.50, df= 1, 
p=0.2206 
PH Trust 
Area 11 
1.02 0.93
Staywell 
Area 11 
1 0.59 Χ2= 27.85, df= 1, 
p=<.0001 
Χ2= 3.16, df= 1, 
p=0.0757 
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Table 11. SED Analysis: Comparison of Psychiatric Services Penetration 
Among Area 5 Plans. 
 
Source Wald
Main Effect of Time Χ2= 74.56, df= 2, p=<.0001
Main Effect of Plan Χ2= 4.03, df= 3, p=0.2586
Time by Plan Interaction Χ2= 49.30, df= 6, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Implementa
tion to 2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 5 
8.90% 13.83% 14.66% Χ2= 0.84, 
df= 1, 
p=0.3595 
Χ2= 0.18, 
df= 1, 
p=0.6684 
Χ2= 18.10, 
df= 1, 
p=<.0001 
FHP Area 5 10.05% 16.70% 9.25%  
Healthease 
AREA 5 
12.47% 13.32% 13.57% Χ2= 1.64, 
df= 1, 
p=0.2000 
Χ2= 3.62, 
df= 1, 
p=0.0571 
Χ2= 1.65, 
df= 1, 
p=0.1993 
Staywell 
Area 5 
8.31% 12.60% 13.46% Χ2= 2.32, 
df= 1, 
p=0.1280 
Χ2= 0.00, 
df= 1, 
p=0.9679 
Χ2= 13.02, 
df= 1, 
p=0.0003 
 
 
Table 12. SED Analysis: Comparison of Psychiatric Services Penetration 
Among Area 7 Plans. 
 
Source Wald
Main Effect of Time Χ2= 64.15, df= 2, p=<.0001
Main Effect of Plan Χ2= 16.70, df= 3, p=0.0008
Time by Plan Interaction Χ2= 89.69, df= 6, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implemen
tation to 
1st 6 
Months 
Compared 
to PMHP 
Change 
from Pre-
Implement
ation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 7 
7.15% 10.36% 9.93% Χ2= 3.00, 
df= 1, 
p=0.0834 
Χ2= 16.48, 
df= 1, 
p=<.0001 
Χ2= 49.42, 
df= 1, 
p=<.0001 
FHP Area 7 5.95% 4.42% 2.06%  
Healthease 
Area 7 
8.71% 12.17% 11.50% Χ2= 9.99, 
df= 1, 
p=0.0016 
Χ2= 17.57, 
df= 1, 
p=<.0001 
Χ2= 47.18, 
df= 1, 
p=<.0001 
Staywell 
Area 7 
7.66% 12.13% 12.32% Χ2= 4.82, 
df= 1, 
p=0.0282 
Χ2= 34.59, 
df= 1, 
p=<.0001 
Χ2= 79.96, 
df= 1, 
p=<.0001 
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Table 13. SED Analysis: Comparison of Psychiatric Services Penetration 
Among Area 2 Plans. 
 
Source Wald
Main Effect of Time Χ2= 21.17, df= 1, p=<.0001
Main Effect of Plan Χ2= 4.39, df= 1, p=0.0362
Time by Plan Interaction Χ2= 6.75, df= 1, p=0.0094
 
Plan Last 6 
Months 
Prior 
First 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 2 
5.16% 5.72% Χ2= 7.53, df= 1, 
p=0.0061 
Χ2= 5.46, df= 1, 
p=0.0194 
Magellan 
Area 2 
2.78% 1.16%
 
 
 
Table 14. SED Analysis: Comparison of Psychiatric Services Penetration 
Among Area 3 Plans. 
 
Source Wald
Main Effect of Time Χ2= 59.74, df= 1, p=<.0001
Main Effect of Plan Χ2= 12.76, df= 2, p=0.0017
Time by Plan Interaction Χ2= 38.14, df= 2, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 3 
4.67% 6.61% Χ2= 3.38, df= 1, 
p=0.0658 
Χ2= 21.91, df= 1, 
p=<.0001 
NFBHP 
Area 3 
3.53% 1.48%
Staywell 
Area 3 
10.02% 9.78% Χ2= 23.09, df= 1, 
p=<.0001 
Χ2= 10.45, df= 1, 
p=0.0012 
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Table 15. SED Analysis: Comparison of Psychiatric Services Penetration 
Among Area 11 Plans. 
 
Source Wald
Main Effect of Time Χ2= 0.06, df= 1, p=0.8029
Main Effect of Plan Χ2= 67.07, df= 3, p=<.0001
Time by Plan Interaction Χ2= 17.86, df= 3, p=0.0005
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 11 
4.88% 4.24% Χ2= 17.89, df= 1, 
p=<.0001 
Χ2= 0.09, df= 1, 
p=0.7609 
Magellan Area 
11 
6.87% 6.59% Χ2= 7.37, df= 1, 
p=0.0066 
Χ2= 0.83, df= 1, 
p=0.3622 
PH Trust 
Area 11 
9.33% 8.84%  
Staywell Area 
11 
3.33% 5.52% Χ2= 41.14, df= 1, 
p=<.0001 
Χ2= 5.02, df= 1, 
p=0.0251 
 
 
Table 16. SED Analysis: Comparison of Psychiatric Services Density Among 
Area 5 Plans. 
 
Source Wald
Main Effect of Time Χ2= 20.35, df= 2, p=<.0001
Main Effect of Plan Χ2= 11.76, df= 3, p=0.0082
Time by Plan Interaction Χ2= 39.59, df= 6, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Implement
ation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 5 
0.34 0.46 0.49 Χ2= 65.44, 
df= 1, 
p=<.0001 
Χ2= 41.30, 
df= 1, 
p=<.0001 
Χ2= 140.29, 
df= 1, 
p=<.0001 
FHP Area 5 0.57 0.38 0.43  
Healthease 
Area 5 
0.32 0.49 0.58 Χ2= 10.09, 
df= 1, 
p=0.0015 
Χ2= 6.92, 
df= 1, 
p=0.0085 
Χ2= 52.19, 
df= 1, 
p=<.0001 
Staywell 
Area 5 
0.39 0.42 0.57 Χ2= 31.56, 
df= 1, 
p=<.0001 
Χ2= 8.48, 
df= 1, 
p=0.0036 
Χ2= 87.53, 
df= 1, 
p=<.0001 
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Table 17. SED Analysis: Comparison of Psychiatric Services Density Among 
Area 7 Plans. 
 
Source Wald
Main Effect of Time Χ2= 0.07, df= 2, p=0.9652
Main Effect of Plan Χ2= 16.23, df= 3, p=0.0010
Time by Plan Interaction Χ2= 0.67, df= 6, p=0.9951
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implemen
tation to 
1st 6 
Months 
Compared 
to PMHP 
Change 
from Pre-
Implemen
tation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigrou
p Area 7 
0.25 0.22 0.28 Χ2= 2.13, 
df= 1, 
p=0.1446 
Χ2= 0.02, 
df= 1, 
p=0.8764 
Χ2= 0.00, 
df= 1, 
p=0.9771 
FHP Area 
7 
0.18 0.18 0.18  
Healthease 
Area 7 
0.22 0.24 0.23 Χ2= 11.55, 
df= 1, 
p=0.0007 
Χ2= 0.11, 
df= 1, 
p=0.7357 
Χ2= 0.00, 
df= 1, 
p=0.9702 
Staywell 
Area 7 
0.2 0.22 0.24 Χ2= 12.73, 
df= 1, 
p=0.0004 
Χ2= 0.00, 
df= 1, 
p=0.9818 
Χ2= 0.32, 
df= 1, 
p=0.5723 
 
 
Table 18. SED Analysis: Comparison of Psychiatric Services Density Among 
Area 2 Plans. 
 
Source Wald
Main Effect of Time Χ2= 18.31, df= 1, p=<.0001
Main Effect of Plan Χ2= 4.75, df= 1, p=0.0293
Time by Plan Interaction Χ2= 12.91, df= 1, p=0.0003
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 2 
0.26 0.5 Χ2= 8.41, df= 1, 
p=0.0037 
Χ2= 52.22, df= 1, 
p=<.0001 
Magellan 
Area 2 
0.86 0.66
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Table 19. SED Analysis: Comparison of Psychiatric Services Density Among 
Area 3 Plans. 
 
Source Wald
Main Effect of Time Χ2= 44.28, df= 1, p=<.0001
Main Effect of Plan Χ2= 17.85, df= 2, p=0.0001
Time by Plan Interaction Χ2= 43.81, df= 2, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 3 
0.33 0.57 Χ2= 45.34, df= 1, 
p=<.0001 
Χ2= 205.16, df= 1, 
p=<.0001 
NFBHP 
Area 3 
1.03 0.55  
Staywell 
Area 3 
0.27 0.52 Χ2= 3.82, df= 1, 
p=0.0505 
Χ2= 109.44, df= 1, 
p=<.0001 
 
 
Table 20. SED Analysis: Comparison of Psychiatric Services Density Among 
Area 11 Plans. 
 
Source Wald
Main Effect of Time Χ2= 3.80, df= 1, p=0.0514
Main Effect of Plan Χ2= 91.91, df= 3, p=<.0001
Time by Plan Interaction Χ2= 14.93, df= 3, p=0.0019
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 11 
0.38 0.62 Χ2= 119.76, df= 1, 
p=<.0001 
Χ2= 12.36, df= 1, 
p=0.0004 
Magellan 
Area 11 
0.67 0.51 Χ2= 38.99, df= 1, 
p=<.0001 
Χ2= 11.89, df= 1, 
p=0.0006 
PH Trust 
Area 11 
0.69 0.6  
Staywell 
Area 11 
0.51 0.45 Χ2= 182.95, df= 1, 
p=<.0001 
Χ2= 16.88, df= 1, 
p=<.0001 
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Table 21. SED Analysis: Comparison of CMH/TCM Services Penetration 
Among Area 5 Plans. 
 
Source Wald
Main Effect of Time Χ2= 37.93, df= 2, p=<.0001
Main Effect of Plan Χ2= 5.41, df= 3, p=0.1439
Time by Plan Interaction Χ2= 21.69, df= 6, p=0.0014
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Impleme
ntation to 
2nd 6 
Months 
Compare
d to 
PMHP 
Amerigroup 
Area 5 
41.17% 38.52% 40.00% Χ2= 5.56, 
df= 1, 
p=0.0183 
Χ2= 1.23, 
df= 1, 
p=0.2675 
Χ2= 1.98, 
df= 1, 
p=0.1591 
FHP Area 5 45.47% 40.24% 40.41%  
Healthease 
Area 5 
43.91% 41.74% 38.38% Χ2= 1.22, 
df= 1, 
p=0.2688 
Χ2= 1.73, 
df= 1, 
p=0.1886 
Χ2= 0.03, 
df= 1, 
p=0.8571 
Staywell 
Area 5 
40.02% 43.16% 37.93% Χ2= 6.26, 
df= 1, 
p=0.0123 
Χ2= 7.78, 
df= 1, 
p=0.0053 
Χ2= 2.28, 
df= 1, 
p=0.1307 
 
 
Table 22. SED Analysis: Comparison of CMH/TCM Services Penetration 
Among Area 7 Plans. 
 
Source Wald
Main Effect of Time Χ2= 105.52, df= 2, p=<.0001
Main Effect of Plan Χ2= 41.51, df= 3, p=<.0001
Time by Plan Interaction Χ2= 64.58, df= 6, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Impleme
ntation to 
2nd 6 
Months 
Compare
d to 
PMHP 
Amerigroup 
Area 7 
40.52% 43.17% 41.28% Χ2= 34.66, 
df= 1, 
p=<.0001 
Χ2= 24.01, 
df= 1, 
p=<.0001 
Χ2= 28.86, 
df= 1, 
p=<.0001 
FHP Area 7 49.09% 41.11% 37.68%  
Healthease 
Area 7 
46.66% 45.86% 44.50% Χ2= 4.42, 
df= 1, 
p=0.0355 
Χ2= 8.63, 
df= 1, 
p=0.0033 
Χ2= 12.61, 
df= 1, 
p=0.0004 
Staywell 
Area 7 
43.31% 44.47% 40.83% Χ2= 20.84, 
df= 1, 
p=<.0001 
Χ2= 25.96, 
df= 1, 
p=<.0001 
Χ2= 21.16, 
df= 1, 
p=<.0001 
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Table 23. SED Analysis: Comparison of CMH/TCM Services Penetration 
Among Area 2 Plans. 
 
Source Wald
Main Effect of Time Χ2= 275.19, df= 1, 
p=<.0001 
Main Effect of Plan Χ2= 4.07, df= 1, p=0.0436
Time by Plan Interaction Χ2= 12.27, df= 1, p=0.0005
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 2 
43.90% 39.54% Χ2= 2.20, df= 1, 
p=0.1382 
Χ2= 8.18, df= 1, 
p=0.0042 
Magellan 
Area 2 
46.52% 31.82%  
 
 
Table 24. SED Analysis: Comparison of CMH/TCM Services Penetration 
Among Area 3 Plans. 
 
Source Wald
Main Effect of Time Χ2= 386.65, df= 1, 
p=<.0001 
Main Effect of Plan Χ2= 10.00, df= 2, p=0.0067
Time by Plan Interaction Χ2= 50.86, df= 2, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 3 
36.18% 32.90% Χ2= 5.27, df= 1, 
p=0.0217 
Χ2= 19.00, df= 1, 
p=<.0001 
NFBHP 
Area 3 
38.92% 24.96%  
Staywell 
Area 3 
44.06% 44.12% Χ2= 1.83, df= 1, 
p=0.1758 
Χ2= 18.86, df= 1, 
p=<.0001 
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Table 25. SED Analysis: Comparison of CMH/TCM Services Penetration 
Among Area 11 Plans. 
 
Source Wald
Main Effect of Time Χ2= 275.82, df= 1, 
p=<.0001 
Main Effect of Plan Χ2= 67.68, df= 3, p=<.0001
Time by Plan Interaction Χ2= 22.06, df= 3, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 11 
33.06% 27.75% Χ2= 33.43, df= 1, 
p=<.0001 
Χ2= 4.11, df= 1, 
p=0.0426 
Magellan 
Area 11 
41.10% 30.82% Χ2= 0.01, df= 1, 
p=0.9204 
Χ2= 2.41, df= 1, 
p=0.1207 
PH Trust 
Area 11 
44.82% 31.80%
Staywell 
Area 11 
33.63% 26.40% Χ2= 42.04, df= 1, 
p=<.0001 
Χ2= 3.01, df= 1, 
p=0.0828 
 
 
Table 26. SED Analysis: Comparison of CMH/TCM Services Density Among 
Area 5 Plans. 
 
Source Wald
Main Effect of Time Χ2= 189.10, df= 2, 
p=<.0001 
Main Effect of Plan Χ2= 52.16, df= 3, p=<.0001
Time by Plan Interaction Χ2= 45.29, df= 6, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Impleme
ntation to 
1st 6 
Months 
Compare
d to 
PMHP 
Change 
from Pre-
Implement
ation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 5 
2.01 1.57 1.53 Χ2=1417.84, 
df= 1, 
p=<.0001 
Χ2= 
346.23, df= 
1, 
p=<.0001 
Χ2= 707.25, 
df= 1, 
p=<.0001 
FHP Area 5 3.15 1.68 1.35  
Healthease 
Area 5 
2.08 1.6 1.85 Χ2= 423.86, 
df= 1, 
p=<.0001 
Χ2= 
153.66, df= 
1, 
p=<.0001 
Χ2= 381.43, 
df= 1, 
p=<.0001 
Staywell 
Area 5 
2.51 1.49 1.54 Χ2= 396.14, 
df= 1, 
p=<.0001 
Χ2= 
107.28, df= 
1, 
p=<.0001 
Χ2= 76.41, 
df= 1, 
p=<.0001 
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Table 27. SED Analysis: Comparison of CMH/TCM Services Density Among 
Area 7 Plans. 
 
Source Wald
Main Effect of Time Χ2= 317.72, df= 2, 
p=<.0001 
Main Effect of Plan Χ2= 16.35, df= 3, p=0.0010
Time by Plan Interaction Χ2= 87.79, df= 6, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Impleme
ntation to 
2nd 6 
Months 
Compare
d to 
PMHP 
Amerigroup 
Area 7 
2.54 1.72 1.81 Χ2= 390.70, 
df= 1, 
p=<.0001 
Χ2= 766.25, 
df= 1, 
p=<.0001 
Χ2= 
833.01, 
df= 1, 
p=<.0001 
FHP Area 7 2.69 1.29 1.37  
Healthease 
Area 7 
2.43 1.26 1.55 Χ2= 150.13, 
df= 1, 
p=<.0001 
Χ2= 114.45, 
df= 1, 
p=<.0001 
Χ2= 
386.78, 
df= 1, 
p=<.0001 
Staywell 
Area 7 
2.74 1.25 1.66 Χ2= 116.52, 
df= 1, 
p=<.0001 
Χ2= 65.50, 
df= 1, 
p=<.0001 
Χ2= 
420.79, 
df= 1, 
p=<.0001 
 
 
Table 28. SED Analysis: Comparison of CMH/TCM Services Density Among 
Area 2 Plans. 
 
Source Wald
Main Effect of Time Χ2= 296.94, df= 1, 
p=<.0001 
Main Effect of Plan Χ2= 2.14, df= 1, p=0.1439
Time by Plan Interaction Χ2= 5.83, df= 1, p=0.0157
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 2 
5.22 2.31 Χ2= 153.49, df= 1, 
p=<.0001 
Χ2= 56.00, df= 1, 
p=<.0001 
Magellan 
Area 2 
4.07 2.94  
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Table 29. SED Analysis: Comparison of CMH/TCM Services Density Among 
Area 3 Plans. 
 
Source Wald
Main Effect of Time Χ2= 278.03, df= 1, 
p=<.0001 
Main Effect of Plan Χ2= 3.99, df= 2, p=0.1362
Time by Plan Interaction Χ2= 2.47, df= 2, p=0.2914
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 3 
2.4 1.63 Χ2= 45.23, df= 1, 
p=<.0001 
Χ2= 66.52, df= 1, 
p=<.0001 
NFBHP 
Area 3 
1.98 1.5
Staywell 
Area 3 
2.34 1.47 Χ2= 136.40, df= 1, 
p=<.0001 
Χ2= 39.01, df= 1, 
p=<.0001 
 
 
Table 30. SED Analysis: Comparison of CMH/TCM Services Density Among 
Area 11 Plans. 
 
Source Wald
Main Effect of Time Χ2= 287.28, df= 1, 
p=<.0001 
Main Effect of Plan Χ2= 26.23, df= 3, p=<.0001
Time by Plan Interaction Χ2= 73.26, df= 3, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 11 
4.49 2.41 Χ2= 176.33, df= 1, 
p=<.0001 
Χ2= 256.67, df= 1, 
p=<.0001 
Magellan 
Area 11 
4 2.61 Χ2= 5.87, df= 1, 
p=0.0154 
Χ2= 721.09, df= 1, 
p=<.0001 
PH Trust 
Area 11 
4.11 3.56
Staywell 
Area 11 
3.72 2.4 Χ2= 879.13, df= 1, 
p=<.0001 
Χ2= 138.32, df= 1, 
p=<.0001 
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Table 31. SMI Analysis: Comparison of Inpatient Services Penetration Among 
Area 5 Plans. 
 
Source Wald
Main Effect of Time Χ2= 1.05, df= 2, p=0.5912
Main Effect of Plan Χ2= 2.41, df= 3, p=0.4917
Time by Plan Interaction Χ2= 2.61, df= 6, p=0.8562
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implemen
tation to 
1st 6 
Months 
Compared 
to PMHP 
Change 
from Pre-
Implement
ation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 5 
9.28% 10.39% 9.13% Χ2= 1.20, 
df= 1, 
p=0.2729 
Χ2= 0.86, 
df= 1, 
p=0.3545 
Χ2= 0.06, 
df= 1, 
p=0.8053 
FHP Area 5 10.36% 10.54% 9.39%  
Healthease 
Area 5 
10.97% 10.56% 12.23% Χ2= 0.05, 
df= 1, 
p=0.8247 
Χ2= 0.09,
df= 1, 
p=0.7645 
Χ2= 0.70, 
df= 1, 
p=0.4014 
Staywell 
Area 5 
12.02% 12.03% 11.82% Χ2= 0.26, 
df= 1, 
p=0.6113 
Χ2= 0.02, 
df= 1, 
p=0.8985 
Χ2= 0.26, 
df= 1, 
p=0.6090 
 
 
Table 32. SMI Analysis: Comparison of Inpatient Services Penetration Among 
Area 7 Plans. 
 
Source Wald
Main Effect of Time Χ2= 8.74, df= 2, p=0.0127
Main Effect of Plan Χ2= 3.69, df= 3, p=0.2969
Time by Plan Interaction Χ2= 12.47, df= 6, p=0.0522
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implemen
tation to 
1st 6 
Months 
Compared 
to PMHP 
Change 
from Pre-
Implement
ation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 7 
6.92% 10.59% 10.32% Χ2= 1.26, 
df= 1, 
p=0.2625 
Χ2= 0.33, 
df= 1, 
p=0.5669 
Χ2= 0.09, 
df= 1, 
p=0.7637 
FHP Area 7 8.37% 11.21% 11.40%  
Healthease 
Area 7 
10.17% 10.27% 9.47% Χ2= 1.19, 
df= 1, 
p=0.2750 
Χ2= 1.65, 
df= 1, 
p=0.1983 
Χ2= 3.26, 
df= 1, 
p=0.0712 
Staywell 
Area 7 
9.58% 8.56% 7.44% Χ2= 0.28, 
df= 1, 
p=0.5975 
Χ2= 3.24, 
df= 1, 
p=0.0720 
Χ2= 6.55, 
df= 1, 
p=0.0105 
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Table 33. SMI Analysis: Comparison of Inpatient Services Penetration Among 
Area 2 Plans. 
 
Source Wald
Main Effect of Time Χ2= 5.67, df= 1, p=0.0173
Main Effect of Plan Χ2= 0.87, df= 1, p=0.3507
Time by Plan Interaction Χ2= 1.96, df= 1, p=0.1610
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 2 
12.11% 13.49% Χ2= 1.14, df= 1, 
p=0.2857 
Χ2= 1.81, df= 1, 
p=0.1784 
Magellan 
Area 2 
8.82% 5.64%
 
 
Table 34. SMI Analysis: Comparison of Inpatient Services Penetration Among 
Area 3 Plans. 
 
Source Wald
Main Effect of Time Χ2= 22.40, df= 1, p=<.0001
Main Effect of Plan Χ2= 7.44, df= 2, p=0.0243
Time by Plan Interaction Χ2= 3.63, df= 2, p=0.1626
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 3 
11.60% 12.40% Χ2= 9.92, df= 1, 
p=0.0016 
Χ2= 2.85, df= 1, 
p=0.0912 
NFBHP 
Area 3 
5.74% 9.57%
Staywell 
Area 3 
7.66% 12.70% Χ2= 1.61, df= 1, 
p=0.2042 
Χ2= 0.25, df= 1, 
p=0.6176 
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Table 35. SMI Analysis: Comparison of Inpatient Services Penetration Among 
Area 11 Plans. 
 
Source Wald
Main Effect of Time Χ2= 3.38, df= 1, p=0.0661
Main Effect of Plan Χ2= 1.76, df= 3, p=0.6237
Time by Plan Interaction Χ2= 9.38, df= 3, p=0.0247
 
Plan Last 6 
Months 
Prior 
First 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
First 6 Months 
Compared to PMHP 
Healthease 
Area 11 
6.08% 1.97% Χ2= 0.38, df= 1, 
p=0.5372 
Χ2= 2.19, df= 1, 
p=0.1390 
Magellan Area 
11 
7.77% 5.77% Χ2= 0.26, df= 1, 
p=0.6110 
Χ2= 3.51, df= 1, 
p=0.0610 
PH Trust 
Area 11 
7.62% 6.70%  
Staywell Area 
11 
7.32% 4.19% Χ2= 0.09, df= 1, 
p=0.7677 
Χ2= 0.51, df= 1, 
p=0.4767 
 
 
Table 36. SMI Analysis: Comparison of Inpatient Services Density Among 
Area 5 Plans. 
 
Source Wald
Main Effect of Time Χ2= 1.94, df= 2, p=0.3786
Main Effect of Plan Χ2= 4.38, df= 3, p=0.2230
Time by Plan Interaction Χ2= 4.01, df= 6, p=0.6754
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implemen
tation to 
1st 6 
Months 
Compared 
to PMHP 
Change 
from Pre-
Implement
ation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 5 
0.82 0.72 0.76 Χ2= 34.89, 
df= 1, 
p=<.0001 
Χ2= 6.85, 
df= 1, 
p=0.0089 
Χ2= 1.91, 
df= 1, 
p=0.1673 
FHP Area 5 1.15 0.83 0.99  
Healthease 
Area 5 
0.84 1.04 1.03 Χ2= 6.79, 
df= 1, 
p=0.0092 
Χ2= 12.80, 
df= 1, 
p=0.0003 
Χ2= 17.74, 
df= 1, 
p=<.0001 
Staywell 
Area 5 
0.89 0.8 1.19 Χ2= 1.45, 
df= 1, 
p=0.2291 
Χ2= 2.53, 
df= 1, 
p=0.1116 
Χ2= 19.66, 
df= 1, 
p=<.0001 
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Table 37. SMI Analysis: Comparison of Inpatient Services Density Among 
Area 7 Plans. 
 
Source Wald
Main Effect of Time Χ2= 6.37, df= 2, p=0.0413
Main Effect of Plan Χ2= 0.12, df= 3, p=0.9891
Time by Plan Interaction Χ2= 6.25, df= 6, p=0.3962
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Impleme
ntation to 
1st 6 
Months 
Compare
d to 
PMHP 
Change 
from Pre-
Impleme
ntation to 
2nd 6 
Months 
Compare
d to 
PMHP 
Amerigroup 
Area 7 
0.94 0.69 1.1 Χ2= 1.15, 
df= 1, 
p=0.2835 
Χ2= 6.23, 
df= 1, 
p=0.0125 
Χ2= 0.00, 
df= 1, 
p=0.9721 
FHP Area 7 0.87 1 1.1  
Healthease 
Area 7 
0.71 0.79 0.89 Χ2= 0.00, 
df= 1, 
p=0.9445 
Χ2= 8.32, 
df= 1, 
p=0.0039 
Χ2= 12.58, 
df= 1, 
p=0.0004 
Staywell 
Area 7 
0.65 0.69 0.77 Χ2= 4.04, 
df= 1, 
p=0.0444 
Χ2= 21.25, 
df= 1, 
p=<.0001 
Χ2= 33.40, 
df= 1, 
p=<.0001 
 
 
Table 38. SMI Analysis: Comparison of Inpatient Services Density Among 
Area 2 Plans. 
 
Source Wald
Main Effect of Time Χ2= 1.54, df= 1, p=0.2143
Main Effect of Plan Χ2= 0.10, df= 1, p=0.7536
Time by Plan Interaction Χ2= 1.30, df= 1, p=0.2548
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healtheas
e Area 2 
0.84 0.96 Χ2= 0.73, df= 1, 
p=0.3942 
Χ2= 15.55, df= 1, 
p=<.0001 
Magellan 
Area 2 
1.03 1.01
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Table 39. SMI Analysis: Comparison of Inpatient Services Density Among 
Area 3 Plans. 
 
Source Wald
Main Effect of Time Χ2= 0.00, df= 1, p=0.9594
Main Effect of Plan Χ2= 2.32, df= 2, p=0.3132
Time by Plan Interaction Χ2= 0.53, df= 2, p=0.7670
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 3 
0.94 0.74 Χ2= 23.93, df= 1, 
p=<.0001 
Χ2= 1.94, df= 1, 
p=0.1641 
NFBHP 
Area 3 
1.23 0.75  
Staywell 
Area 3 
1.58 0.69 Χ2= 22.02, df= 1, 
p=<.0001 
Χ2= 3.69, df= 1, 
p=0.0547 
 
 
Table 40. SMI Analysis: Comparison of Inpatient Services Density Among 
Area 11 Plans. 
 
Source Wald
Main Effect of Time Χ2= 7.83, df= 1, p=0.0051
Main Effect of Plan Χ2= 10.17, df= 3, p=0.0172
Time by Plan Interaction Χ2= 1.39, df= 3, p=0.7087
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healtheas
e Area 11 
0.83 1.21 Χ2= 19.13, df= 1, 
p=<.0001 
Χ2= 2.27, df= 1, 
p=0.1320 
Magellan 
Area 11 
1.28 1.23 Χ2= 5.42, df= 1, 
p=0.0199 
Χ2= 1.14, df= 1, 
p=0.2848 
PH Trust 
Area 11 
1.42 1.19  
Staywell 
Area 11 
1.27 0.95 Χ2= 1.87, df= 1, 
p=0.1718 
Χ2= 8.49, df= 1, 
p=0.0036 
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Table 41. SMI Analysis: Comparison of Psychiatric Services Penetration 
Among Area 5 Plans. 
 
Source Wald
Main Effect of Time Χ2= 78.52, df= 2, p=<.0001
Main Effect of Plan Χ2= 30.90, df= 3, p=<.0001
Time by Plan Interaction Χ2= 123.49, df= 6, 
p=<.0001 
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Implement
ation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 5 
18.88% 30.56% 32.86% Χ2= 9.65, 
df= 1, 
p=0.0019 
Χ2= 48.23, 
df= 1, 
p=<.0001 
Χ2= 96.47, 
df= 1, 
p=<.0001 
FHP Area 5 25.50% 16.72% 10.13%  
Healthease 
AreA 5 
35.63% 37.62% 38.48% Χ2= 10.47, 
df= 1, 
p=0.0012 
Χ2= 8.29, 
df= 1, 
p=0.0040 
Χ2= 29.39, 
df= 1, 
p=<.0001 
Staywell 
Area 5 
33.50% 39.72% 44.68% Χ2= 6.66, 
df= 1, 
p=0.0099 
Χ2= 16.90, 
df= 1, 
p=<.0001 
Χ2= 55.49, 
df= 1, 
p=<.0001 
 
 
Table 42. SMI Analysis: Comparison of Psychiatric Services Penetration 
Among Area 7 Plans. 
 
Source Wald
Main Effect of Time Χ2= 6.29, df= 2, p=0.0431
Main Effect of Plan Χ2= 33.61, df= 3, p=<.0001
Time by Plan Interaction Χ2= 42.81, df= 6, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Implement
ation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 7 
15.86% 21.90% 30.66% Χ2= 1.17, 
df= 1, 
p=0.2789 
Χ2= 3.01, 
df= 1, 
p=0.0829 
Χ2= 25.32, 
df= 1, 
p=<.0001 
FHP Area 7 17.61% 19.67% 16.28%  
Healthease 
Area 7 
22.43% 32.18% 32.95% Χ2= 4.42, 
df= 1, 
p=0.0355 
Χ2= 5.28, 
df= 1, 
p=0.0216 
Χ2= 14.19, 
df= 1, 
p=0.0002 
Staywell 
Area 7 
26.11% 26.39% 30.51% Χ2= 21.61, 
df= 1, 
p=<.0001 
Χ2= 0.52, 
df= 1, 
p=0.4708 
Χ2= 3.37, 
df= 1, 
p=0.0662 
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Table 43. SMI Analysis: Comparison of Psychiatric Services Penetration 
Among Area 2 Plans. 
 
Source Wald
Main Effect of Time Χ2= 0.00, df= 1, p=0.9714
Main Effect of Plan Χ2= 7.25, df= 1, p=0.0071
Time by Plan Interaction Χ2= 0.55, df= 1, p=0.4575
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 2 
10.93% 8.40% Χ2= 14.80, df= 1, 
p=0.0001 
Χ2= 0.49, df= 1, 
p=0.4834 
Magellan 
Area 2 
3.24% 3.30%  
 
 
Table 44. SMI Analysis: Comparison of Psychiatric Services Penetration 
Among Area 3 Plans. 
 
Source Wald
Main Effect of Time Χ2= 59.65, df= 1, p=<.0001
Main Effect of Plan Χ2= 13.45, df= 2, p=0.0012
Time by Plan Interaction Χ2= 25.06, df= 2, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 3 
16.67% 16.42% Χ2= 0.02, df= 1, 
p=0.8783 
Χ2= 7.21, df= 1, 
p=0.0073 
NFBHP 
Area 3 
16.54% 9.80%  
Staywell 
Area 3 
32.37% 44.32% Χ2= 23.01, df= 1, 
p=<.0001 
Χ2= 14.96, df= 1, 
p=0.0001 
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Table 45. SMI Analysis: Comparison of Psychiatric Services Penetration 
Among Area 11 Plans. 
 
Source Wald
Main Effect of Time Χ2= 48.40, df= 1, p=<.0001
Main Effect of Plan Χ2= 45.15, df= 3, p=<.0001
Time by Plan Interaction Χ2= 56.93, df= 3, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 11 
20.77% 30.00% Χ2= 12.13, df= 1, 
p=0.0005 
Χ2= 0.60, df= 1, 
p=0.4375 
Magellan 
Area 11 
29.97% 28.43% Χ2= 12.53, df= 1, 
p=0.0004 
Χ2= 32.37, df= 1, 
p=<.0001 
PH Trust 
Area 11 
34.22% 39.38%
Staywell 
Area 11 
24.33% 30.01% Χ2= 12.13, df= 1, 
p=0.0005 
Χ2= 0.32, df= 1, 
p=0.5696 
 
 
Table 46. SMI Analysis: Comparison of Psychiatric Services Density Among 
Area 5 Plans. 
 
Source Wald
Main Effect of Time Χ2= 45.31, df= 2, p=<.0001
Main Effect of Plan Χ2= 69.87, df= 3, p=<.0001
Time by Plan Interaction Χ2= 104.53, df= 6, 
p=<.0001 
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Implement
ation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 5 
0.35 0.45 0.59 Χ2= 450.79, 
df= 1, 
p=<.0001 
Χ2= 360.35, 
df= 1, 
p=<.0001 
Χ2= 522.27, 
df= 1, 
p=<.0001 
FHP Area 5 1.25 0.63 1.06  
Healthease 
Area 5 
0.35 0.68 0.71 Χ2= 132.68, 
df= 1, 
p=<.0001 
Χ2= 301.52, 
df= 1, 
p=<.0001 
Χ2= 319.50, 
df= 1, 
p=<.0001 
Staywell 
Area 5 
0.4 0.62 0.72 Χ2= 145.50, 
df= 1, 
p=<.0001 
Χ2= 321.75, 
df= 1, 
p=<.0001 
Χ2= 437.53, 
df= 1, 
p=<.0001 
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Table 47. SMI Analysis: Comparison of Psychiatric Services Density Among 
Area 7 Plans. 
 
Source Wald
Main Effect of Time Χ2= 8.10, df= 2, p=0.0174
Main Effect of Plan Χ2= 45.15, df= 3, p=<.0001
Time by Plan Interaction Χ2= 73.59, df= 6, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Impleme
ntation to 
1st 6 
Months 
Compare
d to 
PMHP 
Change 
from Pre-
Implementa
tion to 2nd 
6 Months 
Compared 
to PMHP 
Amerigroup 
Area 7 
0.26 0.44 0.71 Χ2= 140.39, 
df= 1, 
p=<.0001 
Χ2= 61.02, 
df= 1, 
p=<.0001 
Χ2= 270.32, 
df= 1, 
p=<.0001 
FHP Area 7 0.89 0.65 0.62  
Healthease 
Area 7 
0.36 0.54 0.71 Χ2= 86.51, 
df= 1, 
p=<.0001 
Χ2= 
113.55, 
df= 1, 
p=<.0001 
Χ2= 271.03, 
df= 1, 
p=<.0001 
Staywell 
Area 7 
0.3 0.49 0.63 Χ2= 114.41, 
df= 1, 
p=<.0001 
Χ2= 66.86, 
df= 1, 
p=<.0001 
Χ2= 249.57, 
df= 1, 
p=<.0001 
 
 
Table 48. SMI Analysis: Comparison of Psychiatric Services Density Among 
Area 2 Plans. 
 
Source Wald
Main Effect of Time Χ2= 23.78, df= 1, p=<.0001
Main Effect of Plan Χ2= 19.91, df= 1, p=<.0001
Time by Plan Interaction Χ2= 5.23, df= 1, p=0.0222
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 2 
0.24 0.72 Χ2= 52.04, df= 1, 
p=<.0001 
Χ2= 86.20, df= 1, 
p=<.0001 
Magellan Area 
2 
1.22 0.67  
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Table 49. SMI Analysis: Comparison of Psychiatric Services Density Among 
Area 3 Plans. 
 
Source Wald
Main Effect of Time Χ2= 54.84, df= 1, p=<.0001
Main Effect of Plan Χ2= 25.58, df= 2, p=<.0001
Time by Plan Interaction Χ2= 50.70, df= 2, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 3 
0.37 0.52 Χ2= 56.09, df= 1, 
p=<.0001 
Χ2= 91.58, df= 1, 
p=<.0001 
NFBHP 
Area 3 
0.85 0.48
Staywell 
Area 3 
0.54 0.65 Χ2= 5.30, df= 1, 
p=0.0213 
Χ2= 164.34, df= 1, 
p=<.0001 
 
 
Table 50. SMI Analysis: Comparison of Psychiatric Services Density Among 
Area 11 Plans. 
 
Source Wald
Main Effect of Time Χ2= 6.26, df= 1, p=0.0124
Main Effect of Plan Χ2= 58.44, df= 3, p=<.0001
Time by Plan Interaction Χ2= 25.53, df= 3, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 11 
0.47 0.53 Χ2= 54.95, df= 1, 
p=<.0001 
Χ2= 15.04, df= 1, 
p=0.0001 
Magellan 
Area 11 
0.75 0.58 Χ2= 17.51, df= 1, 
p=<.0001 
Χ2= 41.57, df= 1, 
p=<.0001 
PH Trust 
Area 11 
0.72 0.55
Staywell 
Area 11 
0.41 0.71 Χ2= 82.27, df= 1, 
p=<.0001 
Χ2= 54.27, df= 1, 
p=<.0001 
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Table 51. SMI Analysis: Comparison of CMH/TCM Services Penetration 
Among Area 5 Plans. 
 
Source Wald
Main Effect of Time Χ2= 26.49, df= 2, p=<.0001
Main Effect of Plan Χ2= 5.51, df= 3, p=0.1378
Time by Plan Interaction Χ2= 34.12, df= 6, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Implemen
tation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 5 
51.10% 44.54% 46.59% Χ2= 6.09, 
df= 1, 
p=0.0136 
Χ2= 13.17, 
df= 1, 
p=0.0003 
Χ2= 13.05, 
df= 1, 
p=0.0003 
FHP Area 5 44.72% 51.26% 53.47%  
Healthease 
Area 5 
48.34% 44.83% 45.99% Χ2= 1.55, 
df= 1, 
p=0.2131 
Χ2= 6.36, 
df= 1, 
p=0.0117 
Χ2= 5.34, 
df= 1, 
p=0.0208 
Staywell 
Area 5 
48.38% 44.67% 45.85% Χ2= 0.79, 
df= 1, 
p=0.3729 
Χ2= 6.80, 
df= 1, 
p=0.0091 
Χ2= 6.47, 
df= 1, 
p=0.0110 
 
 
Table 52. SMI Analysis: Comparison of CMH/TCM Services Penetration 
Among Area 7 Plans. 
 
Source Wald
Main Effect of Time Χ2= 21.53, df= 2, p=<.0001
Main Effect of Plan Χ2= 8.47, df= 3, p=0.0373
Time by Plan Interaction Χ2= 6.30, df= 6, p=0.3905
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Implemen
tation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 7 
59.14% 53.07% 51.25% Χ2= 0.35, 
df= 1, 
p=0.5530 
Χ2= 0.03, 
df= 1, 
p=0.8601 
Χ2= 0.41, 
df= 1, 
p=0.5228 
FHP Area 7 54.46% 49.18% 51.07%  
Healthease 
Area 7 
54.24% 50.22% 52.82% Χ2= 1.45, 
df= 1, 
p=0.2286 
Χ2= 1.10, 
df= 1, 
p=0.2944 
Χ2= 0.92, 
df= 1, 
p=0.3374 
Staywell 
Area 7 
52.19% 47.33% 52.75% Χ2= 4.58, 
df= 1, 
p=0.0323 
Χ2= 0.34, 
df= 1, 
p=0.5586 
Χ2= 1.46, 
df= 1, 
p=0.2277 
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Table 53. SMI Analysis: Comparison of CMH/TCM Services Penetration 
Among Area 2 Plans. 
 
Source Wald
Main Effect of Time Χ2= 80.47, df= 1, p=<.0001
Main Effect of Plan Χ2= 8.51, df= 1, p=0.0035
Time by Plan Interaction Χ2= 4.53, df= 1, p=0.0332
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 2 
77.10% 73.61% Χ2= 13.37, df= 1, 
p=0.0003 
Χ2= 3.44, df= 1, 
p=0.0636 
Magellan 
Area 2 
58.79% 41.38%
 
 
Table 54. SMI Analysis: Comparison of CMH/TCM Services Penetration 
Among Area 3 Plans. 
 
Source Wald
Main Effect of Time Χ2= 17.94, df= 1, p=<.0001
Main Effect of Plan Χ2= 1.88, df= 2, p=0.3909
Time by Plan Interaction Χ2= 8.90, df= 2, p=0.0117
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 3 
61.04% 59.35% Χ2= 1.31, df= 1, 
p=0.2531 
Χ2= 0.94, df= 1, 
p=0.3334 
NFBHP 
Area 3 
52.59% 57.87%
Staywell 
Area 3 
56.50% 46.22% Χ2= 0.54, df= 1, 
p=0.4605 
Χ2= 4.17, df= 1, 
p=0.0411 
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Table 55. SMI Analysis: Comparison of CMH/TCM Services Penetration 
Among Area 11 Plans. 
 
Source Wald
Main Effect of Time Χ2= 34.64, df= 1, p=<.0001
Main Effect of Plan Χ2= 7.01, df= 3, p=0.0716
Time by Plan Interaction Χ2= 22.63, df= 3, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 11 
60.09% 34.51% Χ2= 9.84, df= 1, 
p=0.0017 
Χ2= 9.16, df= 1, 
p=0.0025 
Magellan Area 
11 
40.65% 38.68% Χ2= 3.18, df= 1, 
p=0.0746 
Χ2= 0.04, df= 1, 
p=0.8447 
PH Trust Area 
11 
39.59% 35.85%  
Staywell Area 
11 
54.18% 36.59% Χ2= 11.26, df= 1, 
p=0.0008 
Χ2= 5.42, df= 1, 
p=0.0199 
 
 
Table 56. SMI Analysis: Comparison of CMH/TCM Services Density Among 
Area 5 Plans. 
 
Source Wald
Main Effect of Time Χ2= 4.03, df= 2, p=0.1334
Main Effect of Plan Χ2= 8.22, df= 3, p=0.0416
Time by Plan Interaction Χ2= 31.59, df= 6, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Implement
ation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 5 
1.22 0.73 0.81 Χ2= 420.29, 
df= 1, 
p=<.0001 
Χ2= 231.91, 
df= 1, 
p=<.0001 
Χ2= 107.77, 
df= 1, 
p=<.0001 
FHP Area 5 2.37 2.06 1.86  
Healthease 
Area 5 
1.12 0.85 1.13 Χ2= 300.23, 
df= 1, 
p=<.0001 
Χ2= 32.97, 
df= 1, 
p=<.0001 
Χ2= 0.20, 
df= 1, 
p=0.6533 
Staywell 
Area 5 
1.39 0.95 1.09 Χ2= 194.05, 
df= 1, 
p=<.0001 
Χ2= 78.43, 
df= 1, 
p=<.0001 
Χ2= 21.20, 
df= 1, 
p=<.0001 
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Table 57. SMI Analysis: Comparison of CMH/TCM Services Density Among 
Area 7 Plans. 
 
Source Wald
Main Effect of Time Χ2= 70.64, df= 2, p=<.0001
Main Effect of Plan Χ2= 16.86, df= 3, p=0.0008
Time by Plan Interaction Χ2= 14.73, df= 6, p=0.0225
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
2nd 6 
Months 
After 
Overall 
Plan 
Means 
Compared 
to PMHP 
Mean 
Change 
from Pre-
Implement
ation to 1st 
6 Months 
Compared 
to PMHP 
Change 
from Pre-
Implement
ation to 
2nd 6 
Months 
Compared 
to PMHP 
Amerigroup 
Area 7 
1.36 0.95 1.04 Χ2= 303.89, 
df= 1, 
p=<.0001 
Χ2= 0.76, 
df= 1, 
p=0.3823 
Χ2= 3.03, 
df= 1, 
p=0.0819 
FHP Area 7 2.34 1.7 1.55  
Healthease 
Area 7 
1.33 0.81 1 Χ2= 564.47, 
df= 1, 
p=<.0001 
Χ2= 12.24, 
df= 1, 
p=0.0005 
Χ2= 18.29, 
df= 1, 
p=<.0001 
Staywell 
Area 7 
1.45 0.79 0.87 Χ2= 619.74, 
df= 1, 
p=<.0001 
Χ2= 61.20, 
df= 1, 
p=<.0001 
Χ2= 0.52, 
df= 1, 
p=0.4692 
 
 
Table 58. SMI Analysis: Comparison of CMH/TCM Services Density Among 
Area 2 Plans. 
 
Source Wald
Main Effect of Time Χ2= 89.03, df= 1, p=<.0001
Main Effect of Plan Χ2= 5.72, df= 1, p=0.0168
Time by Plan Interaction Χ2= 13.14, df= 1, p=0.0003
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP
Healthease 
Area 2 
2.87 2.07 Χ2= 342.21, df= 1, 
p=<.0001 
Χ2= 112.55, df= 1, 
p=<.0001 
Magellan 
Area 2 
2.24 1.31
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Table 59. SMI Analysis: Comparison of CMH/TCM Services Density Among 
Area 3 Plans. 
 
Source Wald
Main Effect of Time Χ2= 7.88, df= 1, p=0.0050
Main Effect of Plan Χ2= 0.53, df= 2, p=0.7666
Time by Plan Interaction Χ2= 12.03, df= 2, p=0.0024
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 3 
1.22 0.87 Χ2= 90.03, df= 1, 
p=<.0001 
Χ2= 29.07, df= 1, 
p=<.0001 
NFBHP 
Area 3 
1.92 1.57  
Staywell 
Area 3 
1.37 0.92 Χ2= 35.95, df= 1, 
p=<.0001 
Χ2= 48.22, df= 1, 
p=<.0001 
 
 
Table 60. SMI Analysis: Comparison of CMH/TCM Services Density Among 
Area 11 Plans. 
 
Source Wald
Main Effect of Time Χ2= 52.04, df= 1, p=<.0001
Main Effect of Plan Χ2= 6.23, df= 3, p=0.1007
Time by Plan Interaction Χ2= 21.47, df= 3, p=<.0001
 
Plan Last 6 
Months 
Prior 
1st 6 
Months 
After 
Overall Plan 
Means Compared 
to PMHP Mean 
Change from Pre-
Implementation to 
1st 6 Months 
Compared to PMHP 
Healthease 
Area 11 
2.6 1.36 Χ2= 118.08, df= 1, 
p=<.0001 
Χ2= 256.36, df= 1, 
p=<.0001 
Magellan 
Area 11 
2.87 2.25 Χ2= 37.27, df= 1, 
p=<.0001 
Χ2= 62.53, df= 1, 
p=<.0001 
PH Trust 
Area 11 
2.84 2.55  
Staywell 
Area 11 
1.6 1.09 Χ2= 57.63, df= 1, 
p=<.0001 
Χ2= 91.20, df= 1, 
p=<.0001 
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Utilization of antipsychotic medications before and after 
PMHP implementation 
 
Introduction 
     In recent years, FMHI has studied the use of antipsychotics in both adult and 
child populations.  This study approaches the issue from a different angle by 
examining the effect of the prepaid mental health plan (PMHP) implementation on 
prescription drug utilization.  As the PMHP program has expanded to cover Medicaid 
participants statewide, it is important to understand the implications for prescription 
drug spending.  While much mental health care shifts to the responsibility of the 
PMHP, prescription drugs remain in the fee-for-service program.  This report 
describes changes in utilization of antipsychotic medications among individuals 
diagnosed with schizophrenia in Areas 2, 3, and 11 with the implementation of the 
PMHP carve-out.  We focus on individuals with schizophrenia because of their high 
costs and high rate of antipsychotic medication use.      
 
Background 
     The separation of responsibility for inpatient and outpatient care from 
prescription drugs creates interesting incentives for managed care organizations.  
Prepaid mental health plans (PMHPs) are financially at risk for inpatient and 
outpatient care, while the state is at risk for prescription drug costs.  As such, plans 
have an incentive to reduce inpatient and outpatient care in order to minimize costs.  
However, there is no benefit to the plan from reducing medication use.  Indeed, 
encouraging adherence to medication guidelines would appear to benefit plans by 
potentially reducing expensive inpatient admissions.  However, adherence is often 
increased by regular and frequent office visits suggesting that office visits and 
medication are complementary goods.  A decrease in office visits can lead to a 
reduction in medication adherence, leading to poorer outcomes.  An alternative view 
is that medication can substitute for psychotherapy.  As such, plans can reduce access 
to office visits as long as medication use increases, without adverse consequences for 
outcomes.  Creating sufficient incentives for both providers and patients to increase 
medication use and adherence presents a challenge to plans. 
Below we provide a very brief overview on the use of antipsychotic medications and 
discuss several studies that have examined how antipsychotic utilization changed with 
the implementation of mental health carve-outs.         
 
Atypical antipsychotics 
    Over recent years atypical antipsychotic use for the treatment of schizophrenia and 
bipolar disorders has increased rapidly in adults (Tandon & Fleischhacker, 2005; 
Patel, Crismon, & Hoagwood, 2005).  Given their high cost, the increased utilization 
has resulted in rapid growth in pharmaceutical expenditures. For example, in Florida’s 
Medicaid program expenditures on antipsychotics grew from $215 million to $268 
million, a 24% increase from FY 2002-03 to FY 2003-04.     
     
 The use of atypical antipsychotics is well established with atypical antipsychotics 
accounting for over 90 percent of the market (Rosenheck, 2005).  Despite the high 
cost, when antipsychotic expenditures are placed in a broader context, there is some 
evidence to suggest a cost neutral or cost advantage to their use in the treatment of 
schizophrenia and related illnesses (Rascati, Johnsrud, Crismon, Lage, & Barber, 
2003) 
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2003). Consequently, some argue that improvements in patient quality-of-life can be 
accomplished at no additional cost (or with some savings) to Medicaid programs.  
However, while these arguments are typically used to justify paying the high cost of 
atypical antipsychotics, the savings with a managed care carve-out are somewhat more 
complicated.  In cases where capitation rates are set based on fee-for-service 
utilization, the  savings accrue to the managed care plan, not Medicaid.  Only in cases 
where capitation rates are set based on managed care encounters will any savings 
accrue to the Medicaid program.     
 
   The present study also examines the inter-relationships between the use of 
antipsychotic medication and adherence.  Numerous studies have found non-
adherence to be a major problem with antipsychotics (Eaddy, Grogg, & Locklear, 
2005; Jones, Barnew, et al 2006; Thieda, Beard, Richter, & Kane, 2003; Weiden et al., 
2004).  Reported rates of non-adherence to antipsychotic medication range from 11% 
to 80%, with an average rate of 50% (Dolder, Lacro, & Jeste, 2003; Lacro et al, 2002; 
Weiden & Olfson, 1995).  Almost 40% of the national annual cost of 
rehospitalization for persons with schizophrenia is attributed to adherence problems 
(Weiden & Olfson, 1995).  
 
Mental health carve-outs and antipsychotic use 
 
     The majority of states carve out mental health benefits.  Studies have considered 
the effects of introducing mental health carve-outs in treatment of individuals with 
schizophrenia and/or individuals taking antipsychotic medications.  The studies, 
outlined below, find mixed results.   
 
     Programs in Utah and Massachusetts are similar to Florida in that prescription 
medications remain a fee-for-service benefit and the managed care plans are not at-
risk for pharmacy costs.  Popkin, Lurie, Manning, Harman, Callies, Gray, & 
Christianson (1998) report on the treatment of individuals diagnosed with 
schizophrenia in Utah’s PMHP program.  PMHP implementation did not adversely 
affect medication management visits, prescriptions, refills, or intramuscular injections.  
However, enrollees in PMHP plans were more likely to be treated for a month or 
longer with suboptimal dosages of antipsychotics. 
 
     Medicaid mental health managed care had little impact on pharmacotherapy for 
people with schizophrenia in Massachusetts (Dickey, Normand, Hermann, Eisen, 
Cortes, Cleary, & Ware, 2003).  No difference was found between managed care 
enrollees and fee-of-service enrollees in adherence to treatment guidelines, although 
adherence was low for both financing methods.  Between 90 and 95% of patients 
were prescribed an antipsychotic however less than half were prescribed within 
recommended dosage ranges. 
 
     Programs in other states included pharmacy in the capitation payment making 
plans at-risk for the costs.  Ray, Daugherty, & Meador (2003) examine continuity of 
antipsychotic therapy after the introduction of the TennCare Partners program which 
carved out mental health benefits from the Medicaid program.  Continuity of 
treatment fell with the introduction of TennCare partners.  In addition, there was a 
shorter duration of therapy, with the difference most pronounced for high-risk 
patients at base line (those receiving depot injections or who had been hospitalized 
for psychosis).    
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     Wallace, Bloom, Hu, & Libby (2005) examined antipsychotic medication use 
among patients with schizophrenia in a Medicaid mental health managed care 
program in Colorado.  Despite significant declines in the number of psychosocial 
visits, probabilities of antipsychotic use increased in areas with managed care, while 
the number of months with filled prescriptions was stable.  
 
Research questions 
1. Did the utilization of antipsychotic medications change after PMHP 
implementation? 
2. Were antipsychotic medications prescribed within recommended dosage 
ranges?  Did this change after PMHP implementation? 
 
Methods    
Data 
     This study focused on Medicaid data from Areas 2, 3, and 11.  The sample was 
limited to individuals continuously enrolled in Medicaid who were not enrolled in an 
HMO for the six months before and after PMHP implementation.  Individuals were 
required to have a diagnosis of schizophrenia (three-digit ICD-9 of 295) in the six 
months prior to PMHP implementation and the six months after PMHP 
implementation.  This restriction was imposed to increase confidence in the accuracy 
of the diagnosis, and to increase the likelihood that the individual was actively 
engaged in the treatment system.        
 
     All prescription claims are used with a therapeutic class denoting an antipsychotic 
medication.  We include both first generation typical antipsychotics and second 
generation atypical antipsychotics.  One potential problem with analyzing prescription 
drug claims is that there is no certainty that a medication is used.  To increase the 
likelihood that the medication was taken, at least two prescriptions are required for 
the specific drug in the time frame under consideration.  For example, an individual 
would need at least two prescriptions for Risperidone in the year before the 
medication was counted. 
 
     The purpose of this study is to compare prescription drug use in the base period 
when all treatment was fee-for-service with the following six months when much of 
the mental health care was covered by a PMHP but prescription drugs remained fee-
for-service.  Several different measures are computed.  In each case, we compute and 
compare these statistics for the periods before and after PMHP implementation.  
Because we only use six months of data pre and post, all statistics are computed using 
five of the six months.  Individuals filling a prescription in month 1 may or may not 
have been taking medication prior to that date.  Thus, in order to know if an 
individual has medication on day 1 of the month, we begin computing utilization 
statistics in month 2.  In that way, we observe whether a prescription was filled in 
month1 and know whether the patient has medication on the first day of month 2.  
Similarly, to accurately attribute utilization to the PMHP period, we do not compute 
utilization statistics for the first month after PMHP implementation.  The observed 
days with medication may be due to a prescription that was filled prior to PMHP 
implementation. 
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Measures 
     First, we examine the penetration rate, measured as the percentage of individuals 
receiving antipsychotic medications.  Second, we examine adherence.  The number of 
days an individual had a prescription for an antipsychotic medication was calculated 
based on the date the prescription was filled and the days supplied (typically 30 days).  
As is common in the literature, we convert days with medication to a medication 
possession ratio (MPR).  The MPR is measured as the proportion of potential days 
that the individual had medication.  Individuals are considered adherent during a 
month if the MPR is at least .8 (Valenstein, Copeland, McCarthy, Zeber, Bingham, & 
Stavenger, 2004).  The third measure, consistency (i.e., whether the person was “on” the 
drug), is the number of 30 day periods for which the individual has a MPR of .8 or 
greater.  Fourth, we examine the simultaneous use of multiple antipsychotic 
medications, typically referred to as polypharmacy.  We count the number of months 
an individual had a medication possession ratio of at least .8 for more than one 
antipsychotic.  This does not represent an exact measure of polypharmacy since 
individuals often switch medications gradually.  Consequently, an individual may have 
multiple medications for a month while the transition to the new medication takes 
place.  However, individuals with 4 or 5 months months of multiple medications are 
likely being treated on a regular basis with more than one antipsychotic.      
 
     While penetration, adherence, consistency, and polypharmacy are important issues, 
there are additional ways that utilization may change.  One potentially important issue 
is whether medications are prescribed within recommended dosage ranges.  There are 
legitimate medical reasons for prescribing outside the recommended dosage range 
however the focus in this report is to compare the time frames before and after 
PMHP implementation.  It is unlikely that there was a substantial shift in the number 
of people who would benefit from medications above or below recommended doses.  
In order to look at this issue, we consider each prescription filled by the individuals in 
the sample without requiring a refill.  The important point is whether the prescription 
is written and filled within the recommended dosage range, not whether the patient 
took the medication.  Whereas the utilization figures are computed including all 
antipsychotic medications, only six atypical antipsychotic medications are included in 
the analysis of dosing patterns (the generic name is provided first with the brand 
name in parentheses): Olanzapine (Zyprexa), Ziprasidone (Geodon), Clozapine 
(Clozarol), Quetiapine (Seqoquel), Risperidone (Risperdal), and Aripiprazole (Abilify).   
 
     The data do not contain a variable denoting daily dose.  Instead we compute the 
daily dose by dividing the quantity supplied by the number of days of medication 
supplied.  This gives us a number of pills per day.  The NDC code is used to merge 
the data with a file containing detailed descriptions for each NDC code including the 
dose per pill.  Thus, the number of pills per day is multiplied by the dose per pill to 
arrive at a daily dose.  Recommended dosage ranges are from the Patient Outcomes 
Research Team (PORT) Report (Lehman, Kreyenbuhl, Buchanan, et al. (2004).    
 
Results 
 Table 1 reports the penetration rates and medication possession ratios for the 
total sample and by demographic groups.  The vast majority of individuals diagnosed 
with schizophrenia are prescribed antipsychotic medications.  Over 92% fill more 
than one prescription for an antipsychotic during the 6 months prior to 
implementation of the PMHP.  Out of the potential 150 days, prescriptions are filled 
covering an average of 120 days or 80% of the potential days. The penetration rate 
remains at 92% in the months after PMHP implementation.  The MPR falls slightly, 
from .803 to .793.   
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     The results vary some across demographic groups.  In the pre-PMHP period, only 
race is statistically significantly related to penetration.  Blacks are less likely to receive 
medication and fill prescriptions covering fewer days than other racial groups.  In the 
post PMHP implementation period, significant differences are found across age 
groups as well racial groups.  The difference results from a reduction in penetration 
for ages 13-20.   
 
     Differences in the number of days of medication are more evident.  Significant 
differences exist across age and race groups in both the pre- and post-PMHP periods.   
Overall, there is a small but consistent decline in the MPR after PMHP 
implementation.  The decline occurs for the overall sample, and across age, gender, 
and racial groups.  However, while consistent across demographic groups, none of 
the declines in MPR over time reach statistical significance (p values are not 
reported).     
 
Table 1 
Descriptive Statistics  
Penetration and medication possession ratios  
 Prior to PMHP Post PMHP Implementation
 Obs. Penetration Days MPR Penetration Days MP
R 
  
Total sample 2005 92.0% 120.5 .803 92.0% 119.0 .793
  
Age  
 13-20 44 84.1% 109.6 .731 79.5% 107.7 .718
 21-54 1495 92.1% 119.6 .797 92.2% 117.8 .785
 55-64 466 92.3% 124.2 .828 92.3% 123.7 .825
p value .2185 .0081 .0332 .0016
  
Gender  
 Male 941 92.5% 121.7 .811 93.0% 120.6 .804
 Female 1064 91.5% 119.4 .796 91.0% 117.5 .783
p value .4520 .1643 .0983 .0584
Race  
 White 455 93.4% 124.4 .829 93.0% 123.3 .822
 Black 356 87.1% 114.2 .761 87.6% 111.5 .743
Hispanic 1010 92.7% 120.9 .806 92.9% 119.5 .797
 Other 184 94.1% 119.8 .799 92.4% 119.2 .795
p value .0045 .0011 .0214 .0001
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     Table 2 examines the consistency of medication use.  In the months prior to 
PMHP implantation, 37% of individuals have an MPR of .8 or more in all five 
months.  With the exception of blacks, the proportion of individuals with an MPR 
above .8 is relatively similar across age, race, and gender groups.  However, only 27% 
of blacks have an MPR of at least .8 in all five months.  Similar to the results for 
penetration and adherence, despite differences between demographic groups, there 
are no significant differences between the pre- and post-PMHP implementation time 
periods.    
 
Table 2  
Consistency of Medication Use 
Number of months with medication possession ratio ≥ .8 (n=2,005) 
 Percentage of individuals 
 Prior to PMHP Post PMHP Implementation
 0  1-2  3-4 5 0 1-2 3-4 5
    
Total sample 13% 19% 31% 37% 15% 17% 33% 35%
    
Age    
13-20 -- -- -- -- -- -- -- --
21-54 13% 20% 31% 36% 14% 18% 33% 35%
55-64 11% 16% 32% 41% 11% 16% 34% 39%
p value .0026   .001
5
    
Gender    
Male 12% 18% 32% 38% 12% 17% 32% 39%
Female 14% 20% 30% 36% 16% 18% 34% 32%
p value .0938   .001
1
    
Race    
White 10% 18% 31% 41% 11% 16% 36% 37%
Black 20% 23% 30% 27% 22% 21% 27% 30%
Hispanic 12% 18% 31% 39% 13% 17% 33% 37%
Other 13% 18% 34% 35% 13% -- 34% 35%
p value .0001   .000
1
Note: -- indicates the cell size is less than 30.   
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     Table 3 contains the number of months an individual had more than one drug 
with a medication possession ratio of at least .8.  The results, reported in Table 5, 
suggest little difference in polypharmacy between the pre and post-implementation 
time periods.  As noted earlier, individuals with only one month of multiple 
medications were likely switching medications.  One the other hand, individuals with 
4 or 5 months of multiple medications are likely being treated on a regular basis with 
more than one antipsychotic.  The table contains frequencies, but the means are also 
informative.  On average, individuals have 1.14 months with multiple medications 
prior to PMHP implementation and 1.13 after.  Thus, similar to the above results, 
there is no substantive difference between the pre- and post-periods.   
 
Table 3 
Number of months with multiple antipsychotics 
 Prior to 
PMHP 
Post PMHP 
Implementation 
 # of people # of people
  
Months 
0 1341 1352
1 108 103
2 97 96
3 96 85
4 126 138
5 238 232
 
    
     Table 4 contains the results for dosing patterns and adherence to recommended 
dosages.  Three findings are noteworthy.  First, 76% of all atypical antipsychotic 
prescriptions are written within recommended dosage ranges (76.0% in the base 
period and 76.8% in the post period).  Second, the percentage varies across brand 
names with over 95% of prescriptions for Abilify written within the recommended 
range down to less than 60% for Clozapine and Seroquel.  Third, and most germane 
to this report is that the percentages do not change systematically between pre- and 
post-PMHP implementation.  The proportion prescribed within range increases for 
four of the five medications, but the differences are not statistically significant, either 
for the overall sample or any specific brand name.    
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Table 4 
Medication dosage compared to recommended ranges among atypical antipsychotics 
 Prior to PMHP Post PMHP Implementation
 Obs. Low Within 
range 
High Obs. Low Within 
range 
High
     
Abilify 1741 4.0% 96.0% 0% 1719 3.7% 96.3% 0%
    
Clozapine 492 32.7% 58.1% 9.1% 434 30.6% 59.9% 9.5%
    
Geodon 1008 21.0% 77.4% 1.6% 1062 21.8% 76.7% 1.5%
    
Risperdal 2785 9.9% 86.8% 3.3% 2578 9.8% 87.0% 3.2%
    
Seroquel 3134 29.9% 55.8% 14.3%
2766
30.0% 56.5% 13.3%
    
Zyprexa 1100 7.9% 82.0% 10.0% 1173 8.2% 79.0% 12.7%
     
 
Discussion 
     Earlier we discussed how PMHPs have incentives that may lead to increases or 
decreases in antipsychotic medication use.  We found little difference between the 
months prior to PMHP implementation and months after.  Penetration, adherence, 
consistency of medication use were all similar in the two time periods.  In addition, 
implementation of the managed care carve-out did not lead to changes in dosages, the 
rate of prescribing within recommended dosage ranges, or use of multiple 
antipsychotics.  Thus, either the PMHP did not act on the incentives, was unable to 
influence patient care or adherence to treatment, or felt that antipsychotic medication 
was already being optimally prescribed. 
 
     The results for Florida are, in some ways, similar to other states that have 
implemented mental health managed care carve-outs.  Popkin et al. (1998) and Dickey 
et al. (2003) also found that patient use of antipsychotic medications was not 
adversely affected by the implementation of mental health carve-outs that did not 
capitate prescription drugs.  Although Dickey et al. (2003) found that less than half of 
antipsychotic prescriptions were within recommended dosage ranges, much lower 
than the 76% found in Florida.  Popkin et al. (1998) found that enrollees in PMHPs 
were more likely to be treated with suboptimal dosages, but we found no such effect.   
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High Cost Users 
Introduction 
     Research has shown that the implementation of prospective payment systems has 
the greatest effect on high cost patients (Meltzer, Chung, and Basu, 2002).  Most 
patients have little or no change in their treatment for a given condition.  High cost 
patients, however, tend to have a significant decline in treatment.  Thus, it is 
important to examine the effect of moving towards capitated or prospective payment 
systems for high-cost patients.  These patients are perhaps most vulnerable to 
disruptions in care that may result during the transition from a fee-for-service to 
managed care environment.   
 
     The state of Florida has implemented a carve-out managed care program for 
mental health.  Given the well-known financial incentives for managed care 
organizations (MCOs) to limit services, it is important to evaluate whether enrollees 
are receiving adequate care.  Indeed, the Agency for Healthcare Administration 
(AHCA) has contracted with the Florida Mental Health Institute (FMHI) to evaluate 
the Prepaid Mental Health Plans (PMHP) for many years.   
 
     While FMHI has examined the effect of transitioning from fee-for-service to 
managed care for individuals with severe mental illness, even within this population 
there are significant differences in severity and utilization.  The point of this small 
study is to focus on a specific group of patients, namely high cost enrollees.  We 
define cohorts of high cost users and examine how their treatment changed as they 
moved to a managed care environment.  We also develop models for identifying 
future high cost enrollees, and explore whether such methods are useful for 
identifying future high cost enrollees.  Identification of future high cost users may 
enable cost effective targeted interventions.    
 
Background 
Literature Review 
     Several studies examine high cost enrollees.  Not surprisingly, individuals with 
poorer health status are more likely to have higher costs.  For example, Luekefeld, 
Hiller, Webster, Tindall, Martin, Duvall, et al. (2006) examine high-cost users of 
health care after release from prison.  Health status is the strongest predictor of 
utilization in the following year.  Buck, Teich, and Miller (2003) distinguish between 
physical health and mental health when examining high-cost users in a Medicaid
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population.  An individual is considered high-cost if their expenditures are in the top 
decile.  Over 30% of high-cost users are users of mental health services, and mental 
health services account for one-third of expenditures for high-cost enrollees.   
 
     The payment system used by payers can have important implications for treatment 
patterns.  Meltzer, Chung, and Basu (2002) examine high cost admissions with the 
implementation of Medicare’s Prospective Payment System.  Costs fell for high-cost 
patients after the PPS was implemented.  The authors state that the reduced spending 
among high-cost patients requires “careful assessment of these patients’ outcomes.” 
(p. 447). 
 
     Several studies examine the ability of diagnostic models to identify high-cost 
individuals, although none of these studies focus on mental health costs or diagnoses.  
Ash, Zhao, Ellis, and Kramer (2002) compare two methods, one based on prior cost 
and a second based on the diagnostic cost group (DCG) risk model, to project high 
cost cases in the following year.  The two methods tend to identify different people as 
being high-cost, with only a 38% overlap.  The DCG model does a better job of 
identifying individuals who are high cost in the following year.  The authors discuss 
how risk models can be used to identify individuals for disease management 
programs. 
 
     Meenan, O’Keefe-Rosetti, Hornbrook, Bachman, Goodman, Fishman, and 
Hurtado (1999) also compare risk models with prior costs.  The authors use the 
Global Risk-Assessment Model (GRAM) and compare with prior year costs to 
predict who will be high-cost in the following year.  The authors also find that the 
risk model performed better at identifying high-cost individuals in the following year.  
This study also highlights the potential use of risk models to identify patients for care 
management.     
 
     Maguire, Powe, Starfield, Andrews, Weiner, and Anderson (1998) use Medicaid 
data to determine which diagnoses are associated with high costs.  They determine 
the diseases that have average costs above $25,000.  Forty one diagnosis groups are 
identified as high-cost diagnoses with these diagnoses accounting for 20% of high-
cost enrollees. 
 
     The above studies suggest that diagnostic models can predict who will be high 
cost in the following year.  While these studies focus on physical health, Ford, 
Trestman, Tennan, Allen (2005) focus on mental health diagnoses to examine the 
persistence of high costs.   The authors find that individuals diagnosed with anxiety 
disorders remain high cost users in the following year, but individuals with depression 
and alcohol disorders are less likely to remain high cost.  These results also suggest 
that prior cost alone is not adequate to determine prospective high costs.  
 
     Identifying high cost individuals can have important implications for treatment.  
As indicated by several of the studies, high cost individuals may benefit from 
intensive case management to improve outcomes and reduce costs.  In an example of 
such an application, Quinlivan (2000) discusses how assertive community treatment 
can be used effectively with high-cost patients in a managed care environment.  The 
author discusses how Kaiser Permanente has implemented an intervention with high-
cost users of care in order to more effectively manage their care and reduce costs. 
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Methods for identifying high cost individuals 
       
Determining who will be a high cost person presents several challenges.  Below we 
discuss several methods consistent with the existing literature, and present some 
benefits and shortcomings to each approach.   
 
     First, we define individuals as high cost if they are in the top 10 percent of costs in 
the base period.  This has the benefit of being easy to compute and understand.  The 
shortcoming is that average costs often fall in the future for individuals with high 
costs in the current period.  The reason for this is that individuals are high cost 
because they have a high cost illness or high cost events such as hospitalizations.  For 
individuals with an acute illness or hospitalization for an acute event, many who are 
high cost in one time period will not be high cost in the following period.  The 
tendency for some people to move towards the average over time is typically called 
“regression to the mean”.  In a study such as this one, that tendency is problematic 
since it would appear that people who are high cost pre-PMHP have a decline in 
service use with the implementation of the PMHP.  However, this may simply 
indicate that some people who are high cost in one year will have lower costs in the 
following year, regardless of whether the coverage is through fee-for-service or a 
managed care plan.  Thus, we develop several alternative methods for classifying high 
cost individuals.   
 
     Second, we use a diagnostic risk model to determine who has diagnoses associated 
with high costs.  The model is consistent with the diagnostic risk models discussed 
above, but with a focus on mental health diagnoses and PMHP covered services.  
Thus, instead of classifying an individual as high cost based on an individual’s 
treatment, the determination is based on whether the individual has a diagnosis that 
typically incurs high costs.  The primary criticism of this method is that acute 
diagnoses will predict higher costs in the base period, and thus increase the likelihood 
of an individual being classified as high cost.  However, acute diagnoses may not be 
indicative of high costs in the following period. 
 
     The third measure combines aspects of the first two.  We examine the difference 
between actual costs and predicted costs from the risk model.  Individuals with a 
greater difference may have more severe manifestations of a disease.  As such, these 
individuals may be expected to remain more costly over time. 
 
     The last measure is based on a prospective diagnostic risk model.  A prospective 
model predicts future costs based on current diagnoses.  Thus, this method considers 
who is expected to be expensive in the follow-up period based on their diagnoses in 
the base period.  This measure has the benefit of avoiding base period utilization, 
only using the diagnostic profile from the base period.  As such, it avoids the 
“regression to the mean” problem that we may have with the other measures.     
  
     The measure based on prior costs is straightforward, but the others require further 
explanation.  Below we provide more detail on the use of concurrent and prospective 
risk models to categorize high-cost individuals. 
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Study Issues/Hypotheses 
 
     This study used administrative claims data to assess whether we can develop 
methods for identifying high cost users of mental health services.  The models are 
used to examine the effect of transitioning for a fee-for-service to managed care 
environment for high cost users.  The goal was to better understand the treatment 
patterns for high cost users and determine whether future high cost users can be 
identified for potential intervention.   
  
The study addressed two primary questions.   
• Can we develop models that determine who will be high cost in future time 
periods?  Do these models perform better than prior cost methods?   
• How did treatment change for high cost users when they transitioned to a 
managed care environment?  
 
Methods 
 
Data 
 
     Florida Medicaid enrollment and claims files are the data source for this paper.  
This study focused on Medicaid data from Areas 2, 3, and 11.  The sample was 
limited to children with severe emotional disturbance (SED) and adults with serious 
mental illness (SMI) who were continuously enrolled in Medicaid and not enrolled in 
an HMO for the six months before and after PMHP implementation.  We use six 
months of data prior to PMHP implementation and six months of data after PMHP 
implementation.  Because the PMHP was implemented at a different time Area 11 
(8/1/06) than Areas 2 and 3 (10/1/06), we use slightly different time frames in Area 
11 (2/1/06 – 1/31/07) and Areas 2 and 3 (4/1/06 – 3/31/07).  Critical enrollment 
data include beneficiary demographics (age, sex, race, and eligibility status), Medicaid 
coverage periods, managed care coverage periods, and third party coverage periods.  
Medicaid costs and ICD-9 diagnoses are available from inpatient, outpatient, and 
physician settings.       
 
The grouper 
 
      The ICD-9-CM diagnoses are clustered within groups homogeneous both 
clinically and in costs. HMOs are responsible for all physical and mental health 
services.  However, PMHPs are responsible for services related to a specified list of 
mental health ICD-9 codes.  Thus, only the ICD-9 codes specified in the PMHP 
contract are included in the analysis and clustered into diagnostic groups.  The final 
model aggregates the diagnoses to 22 diagnostic categories.  Such aggregation resulted 
from clinical consultation, similar cost coefficients across more disaggregated groups, 
and small sample sizes for some disaggregated cells.  We also included two categories 
denoting the receipt of case management services.  Such services are common among 
this population and predictive of much higher service use. Hierarchies are imposed 
such that, for a person, only the most serious manifestation of a disease is counted.  
For example, if a person was coded with episodic mood disorders such as major 
depression (296.2 or 296.3) and depressive disorder, nec (311.X), only the more 
severe manifestation would be counted.    
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The model 
     Two multivariate regression models are estimated, one with base period 
expenditures (i.e., the six months prior to PMHP implementation) as the dependent 
variable, and a second with post period expenditures (i.e., the six months after PMHP 
implementation).  In both specifications, the independent variables are all measured 
in the base period and include a vector of demographic characteristics and diagnostic 
groups.  Demographics include age (0-5, 6-13, 14-20, 21-54; 55-64 is the reference 
category), race (black, other; white is the reference category), gender (male), and 
eligibility status (SSI).  The coefficients represent the expenditure weights, which are 
additive, meaning they are summed for each person to determine their case mix score.  
The case mix score is defined as the predicted value from the regression normalized 
to a population mean of 1.0. 
 
High cost 
 
     As discussed above, we use four methods for classifying individuals as high cost.  
The first merely takes the top 10% of individuals with the highest costs for PMHP 
covered services (i.e., services that would have been covered by the PMHP) in the 
pre-implementation period.  The second method uses the results from the concurrent 
case-mix model.  Individuals with the top 10% of the highest case-mix scores are 
classified as high cost.  The third method compares actual costs with predicted costs 
from the model.  Individuals with the top 10% in residual (actual minus predicted) 
costs are classified as high cost.  Lastly, we use the results from the prospective case 
mix model, classifying individuals with the top 10% of prospective case-mix scores as 
high cost. The model 
     Two multivariate regression models are estimated, one with base period 
expenditures (i.e., the six months prior to PMHP implementation) as the dependent 
variable, and a second with post period expenditures (i.e., the six months after PMHP 
implementation).  In both specifications, the independent variables are all measured 
in the base period and include a vector of demographic characteristics and diagnostic 
groups.  Demographics include age (0-5, 6-13, 14-20, 21-54; 55-64 is the reference 
category), race (black, other; white is the reference category), gender (male), and 
eligibility status (SSI).  The coefficients represent the expenditure weights, which are 
additive, meaning they are summed for each person to determine their case mix score.  
The case mix score is defined as the predicted value from the regression normalized 
to a population mean of 1.0. 
 
High cost 
 
     As discussed above, we use four methods for classifying individuals as high cost.  
The first merely takes the top 10% of individuals with the highest costs for PMHP 
covered services (i.e., services that would have been covered by the PMHP) in the 
pre-implementation period.  The second method uses the results from the concurrent 
case-mix model.  Individuals with the top 10% of the highest case-mix scores are 
classified as high cost.  The third method compares actual costs with predicted costs 
from the model.  Individuals with the top 10% in residual (actual minus predicted) 
costs are classified as high cost.  Lastly, we use the results from the prospective case 
mix model, classifying individuals with the top 10% of prospective case-mix scores as 
high cost. 
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Results 
     The pre-PMHP sample has 20,444 observations, and the post-PMHP 
implementation sample has 18,735 people classified as either SMI or SED.  
Descriptive statistics are in Table 1.  Not surprisingly, the demographic characteristics 
are quite similar between the samples.  There are however, some notable differences 
in penetration, service days, and costs between the time periods.  Penetration is lower 
across all service categories, and service days are lower across all categories except 
“other” medical services.  Lastly, costs are lower for PMHP covered services but 
increase for medical services.  There is a small, but notable, decline in the prevalence 
of several diagnostic categories.  For example, Hyperkinetic syndrome of childhood 
(primarily ADHD) declines from 18.3% of the sample to 15.6%. 
 
Table 1    
Variable means    
        
 
Prior to 
PMHP  
Post 
PMHP 
Variable Mean   Mean 
    
Age    
Age 1-5 3.5%  2.2% 
Age 6-12 28.0%  25.8% 
Age 13-20 24.7%  25.9% 
Age 21-54 32.3%  33.4% 
Age 55-64 11.5%  12.7% 
    
Gender    
Female 51.4%  52.0% 
    
Race    
White 26.7%  25.5% 
Black 16.7%  17.3% 
Hispanic 42.2%  42.5% 
Other 14.4%  14.7% 
    
Penetration    
Inpatient 4.2%  3.0% 
Outpatient 2.0%  1.4% 
Psychiatric 16.0%  15.0% 
CMH 43.7%  36.0% 
Medical 33.3%  30.6% 
Other 8.9%  8.6% 
    
Service days    
Inpatient 0.29  0.19 
Outpatient 0.03  0.02 
Psychiatric 0.70  0.49 
CMH 8.19  5.09 
Medical 1.20  0.96 
Other 1.27 1.27
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Costs    
Inpatient $579  $239
Outpatient $7  $6
Psychiatric $37  $28
CMH $535  $331
Medical $210  $244
Other $90  $71
    
Diagnostic groups    
Persistent mental disorders classified elsewhere 0.3%  0.4%
Transient mental disorders due to conditions classified 
elsewhere 0.4%  0.3%
Schizophrenic disorders 12.7%  12.5%
Schizophrenic disorders - chronic w/ acute 
exacerbation 2.9%  1.9%
Episodic mood disorders 8.4%  7.5%
Episodic mood disorders - severe 17.0%  16.3%
Delusional disorders 0.1%  0.1%
Other nonorganic psychoses 1.9%  1.7%
Anxiety, dissociative, and somatoform disorders 7.3%  5.8%
Personality disorders 0.3%  0.2%
Physiological malfunction arising from mental factors 0.0%  0.0%
Special symptoms, nec 0.6%  0.7%
Eating disorders 0.1%  0.1%
Acute reaction to stress and adjustment reaction 4.6%  2.7%
Specific nonpsychotic mental disorders due to brain 
damage 0.1%  0.1%
Depressive disorder nec 3.2%  2.8%
Conduct disorder 3.3%  2.3%
Disturbance of emotions specific to childhood and 
adolescence, unspecified 2.3%  1.7%
Disturbance of emotions specific to childhood and 
adolescence 0.3%  0.2%
Hyperkinetic syndrome of childhood 18.3%  15.6%
Specific delays in development 4.7%  4.5%
Targeted case management  - children  9.0%  0.0%
Targeted case management - adults 8.2%  0.0%
No diagnoses 1.5%  2.0%
    
 20444  18735
        
 
     The regression results for the concurrent case-mix model are in Table 2.  Among 
the demographic variables, younger individuals tend to be have higher costs than 
older enrollees.  Whites have higher costs, and Blacks and Hispanics have lower costs, 
than the omitted category of “other” races.  Males have higher costs than females.  
Among the diagnostic groups, some of the higher cost groups include schizophrenia, 
episodic mood disorders, personality disorders, and eating disorders.  Both 
procedures included in the model, target case management – children and targeted 
case management – adults are associated with higher costs.   
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Table 2   
Concurrent model   
       
  Coef 
Std 
err p value
   
Intercept -6.538 0.815 <.0001
   
White -1.129 0.491 0.0215
Black 0.481 0.511 0.3468
Hispanic -0.290 0.459 0.5279
   
Male 1.178 0.287 <.0001
   
Age 1-5 8.581 0.971 <.0001
Age 6-12 8.393 0.671 <.0001
Age 13-20 6.473 0.613 <.0001
Age 21-54 2.465 0.467 <.0001
   
Diagnostic groups   
Persistent mental disorders classified elsewhere 12.003 2.287 <.0001
Transient mental disorders due to conditions classified 
elsewhere 15.579 2.125 <.0001
Schizophrenic disorders 18.136 0.500 <.0001
Schizophrenic disorders - chronic w/ acute exacerbation 80.373 0.853 <.0001
Episodic mood disorders 18.858 0.522 <.0001
Episodic mood disorders - severe 16.513 0.453 <.0001
Delusional disorders 7.292 4.730 0.1231
Other nonorganic psychoses 11.475 0.987 <.0001
Anxiety, dissociative, and somatoform disorders 12.938 0.513 <.0001
Personality disorders 16.382 2.422 <.0001
Physiological malfunction arising from mental factors -3.153 6.308 0.6172
Special symptoms, nec 1.180 1.652 0.4751
Eating disorders 24.274 5.065 <.0001
Acute reaction to stress and adjustment reaction 14.851 0.649 <.0001
Specific nonpsychotic mental disorders due to brain damage 5.128 4.737 0.279
Depressive disorder nec 14.246 0.760 <.0001
Conduct disorder 15.685 0.754 <.0001
Disturbance of emotions specific to childhood and 
adolescence, unspecified 16.883 0.886 <.0001
Disturbance of emotions specific to childhood and 
adolescence 16.175 2.433 <.0001
Hyperkinetic syndrome of childhood 11.200 0.415 <.0001
Specific delays in development -0.925 0.657 0.159
Targeted case management  - children  27.385 0.514 <.0001
Targeted case management - adults 30.675 0.529 <.0001
   
SSI 0.373 0.376 0.3215
   
Observations 20444  
R-Square 0.5659  
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     The regression results for the prospective case-mix model are in Table 3.  There 
are several similarities between the concurrent and prospective models.  For example, 
males are also more expensive in the following year.  Among the diagnostic groups, 
some of the higher cost groups include schizophrenia, episodic mood disorders, 
personality disorders, and eating disorders.  Thus diagnostic groups associated with 
higher current year costs are also related to future costs.  Both procedures included in 
the model, target case management – children and targeted case management – adults 
are also associated with higher costs in the following year.   
 
     There are a few differences between the models.  Age and race are not as strongly 
related to following year costs in the prospective model, as they are to current year 
costs.  Individuals eligible for Medicaid due to SSI were not more costly in the 
concurrent model, but are in the prospective model.   
 
Table 3    
Prospective model    
        
  Coef 
Std 
err 
p 
value 
    
Intercept 2.296 0.892 0.0101 
    
White -0.949 0.539 0.0784 
Black 0.160 0.559 0.7743 
Hispanic 0.704 0.498 0.1575 
    
Male 1.179 0.320 0.0002 
    
Age 1-5 0.782 1.220 0.5215 
Age 6-12 -0.062 0.740 0.9335 
Age 13-20 -2.218 0.664 0.0008 
Age 21-54 1.530 0.485 0.0016 
    
Diagnostic groups    
Persistent mental disorders classified elsewhere 4.656 2.307 0.0436 
Transient mental disorders due to conditions classified 
elsewhere 3.778 2.172 0.082 
Schizophrenic disorders 7.540 0.534 <.0001 
Schizophrenic disorders - chronic w/ acute exacerbation 28.061 0.908 <.0001 
Episodic mood disorders 5.629 0.570 <.0001 
Episodic mood disorders - severe 3.605 0.490 <.0001 
Delusional disorders -1.566 5.412 0.7724 
Other nonorganic psychoses 0.840 1.035 0.417 
Anxiety, dissociative, and somatoform disorders 5.052 0.583 <.0001 
Personality disorders 4.797 2.665 0.0719 
Physiological malfunction arising from mental factors -2.945 7.328 0.6878 
Special symptoms, nec -0.264 1.930 0.8911 
Eating disorders 19.505 5.183 0.0002 
Acute reaction to stress and adjustment reaction 3.500 0.807 <.0001 
Specific nonpsychotic mental disorders due to brain damage -2.303 5.988 0.7005 
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Depressive disorder nec 5.133 0.867 <.0001
Conduct disorder 5.304 0.880 <.0001
Disturbance of emotions specific to childhood and 
adolescence, unspecified 8.723 1.037 <.0001
Disturbance of emotions specific to childhood and 
adolescence 8.891 2.692 0.001
Hyperkinetic syndrome of childhood 6.203 0.477 <.0001
Specific delays in development -1.320 0.748 0.0775
Targeted case management  - children  15.329 0.599 <.0001
Targeted case management - adults 23.931 0.553 <.0001
   
SSI 1.970 0.429 <.0001
   
Observations 14948  
R-Square 0.3028  
       
 
     Using the results from the case-mix models, we have four different methods for 
determining who is a high-cost individual.  One question is whether these methods 
classify the same people or different people as high-cost.  Clearly, if the methods tend 
to classify the same people as high-cost, then a single method would be sufficient.  
However, if the methods classify people differently, it is important to see how the 
results vary across methods and if one method (or a combination of methods) 
identifies individuals at greater risk when managed care is implemented. 
 
     Table 4 reports how individuals are classified under each method.  Over 79% of 
people are not classified as high-cost by any of the four methods.  Among those who 
are classified as high-cost, there exists considerable variability in how people are 
classified.  For example, 273 people are only classified as high cost by the prospective 
model.  Another 545 are classified as high cost by both case-mix methods, but are not 
classified as high cost by the actual cost or residual methods.  Only 345 (or 2.4% of 
the sample) are classified as high-cost by all four methods.    
 
Table 4      
Distribution of people across definitions of "high cost"   
            
Measure of high cost   
Cost Concurrent Concurrent Prospective People %
  prediction residual prediction    
0 0 0 0 11835 79.17
0 0 0 1 273 1.83
0 0 1 0 568 3.8
0 1 0 0 225 1.51
0 1 0 1 545 3.65
1 0 0 0 182 1.22
1 0 0 1 28 0.19
1 0 1 0 469 3.14
1 0 1 1 51 0.34
1 1 0 0 112 0.75
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1 1 0 1 245 1.64 
1 1 1 0 58 0.39 
1 1 1 1 357 2.39 
    14948  
      
 
     Table 5 examines whether the case mix models do a better job of identifying 
future high cost individuals than prior use methods.  Interestingly, the prior cost 
model does better than the risk models at identifying high cost individuals.  Post 
PMHP implementation costs are highest among all four PMHP carve-out cost 
categories for individuals classified as high cost by the prior cost method.   
 
     We also considered whether combinations of the methods would do better than 
any single method at identifying high cost individuals.  We report results for 
individuals who were classified as high cost by both the concurrent and prospective 
models, and by the prior cost and prospective models.  As reported in Table 5, the 
combination of the concurrent and prospective models doesn’t really do better at 
identifying high cost individuals than the prior use model.  The combination of the 
prior use method and prospective risk model performs best.  While only 681 people 
are identified as high cost, their average utilization is by far the highest.  In addition, 
64% of the individuals were in the top decile of costs in the post-period.  Thus, the 
combination of methods does have potential for identifying individuals that may 
benefit from intervention.    
 
Table 5     
Variable means for high cost groups    
Post period     
          
 Measure of high cost 
 Cost Concurrent Concurrent Prospective Cost + 
Variable   prediction residual prediction Prospective 
      
Penetration      
Inpatient 17.2% 15.6% 13.1% 15.0% 28.5% 
Outpatient 5.5% 5.6% 4.6% 5.4% 8.8% 
Psychiatric 24.0% 24.1% 19.4% 24.1% 35.4% 
CMH 74.1% 70.4% 70.4% 75.7% 74.2% 
Medical 45.4% 47.5% 38.1% 49.0% 59.6% 
Other 19.5% 21.6% 15.4% 20.2% 28.9% 
      
Service days      
Inpatient 1.13 0.99 0.94 0.96 1.82 
Outpatient 0.09 0.09 0.07 0.09 0.15 
Psychiatric 1.47 1.37 1.20 1.39 2.41 
CMH 25.08 17.99 20.67 18.71 28.99 
Medical 2.05 2.03 1.64 2.09 3.15 
Other 2.15 2.19 1.61 1.69 2.51 
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Cost      
Inpatient 1634 1470 1338 1463 2891
Outpatient 25 27 19 29 46
Psychiatric 87 79 70 81 140
CMH 1712 1225 1421 1357 2165
Medical 689 639 514 695 984
Other 220 257 172 257 372
      
Diagnostic groups      
Persistent mental 
disorders classified 
elsewhere 1.2% 1.0% 0.9% 1.3% 2.1%
Transient mental 
disorders due to 
conditions classified 
elsewhere 0.5% 0.5% 0.3% 0.5% 0.7%
Schizophrenic 
disorders 27.6% 37.8% 20.6% 45.6% 48.5%
Schizophrenic 
disorders - chronic 
w/ acute 
exacerbation 12.6% 14.8% 8.8% 15.1% 25.6%
Episodic mood 
disorders 11.4% 15.0% 9.4% 14.3% 15.4%
Episodic mood 
disorders - severe 17.4% 12.8% 16.1% 23.2% 20.4%
Delusional disorders 0.1% 0.1% 0.1% 0.1% 0.1%
Other nonorganic 
psychoses 1.6% 1.7% 1.7% 1.4% 1.2%
Anxiety, dissociative, 
and somatoform 
disorders 8.4% 7.3% 9.4% 7.5% 9.1%
Personality disorders 0.5% 0.6% 0.5% 0.6% 0.7%
Physiological 
malfunction arising 
from mental factors 0.1% 0.1% 0.0% 0.1% 0.1%
Special symptoms, 
nec 0.8% 1.2% 0.7% 1.1% 0.9%
Eating disorders 0.1% 0.1% 0.1% 0.1% 0.1%
Acute reaction to 
stress and 
adjustment reaction 4.2% 5.1% 3.7% 2.7% 3.1%
Specific 
nonpsychotic mental 
disorders due to 
brain damage 0.2% 0.1% 0.2% 0.1% 0.1%
Depressive disorder 
nec 4.7% 4.9% 4.8% 3.1% 4.3%
Conduct disorder 4.7% 5.1% 4.0% 1.3% 2.1%
Disturbance of 
emotions specific to 
childhood and 
adolescence, 
unspecified 4.5% 4.7% 4.1% 1.2% 1.6%
Disturbance of 
emotions specific to 
childhood and 
adolescence 0.5% 0.7% 0.1% 0.3% 0.7%
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Hyperkinetic 
syndrome of 
childhood 23.0% 9.9% 25.6% 2.9% 3.8% 
Specific delays in 
development 4.7% 3.4% 4.9% 0.7% 0.7% 
Targeted case 
management  - 
children  0.0% 0.0% 0.0% 0.0% 0.0% 
Targeted case 
management - adults 0.0% 0.0% 0.0% 0.0% 0.0% 
No diagnostic groups 1.5% 2.2% 1.3% 2.0% 1.8% 
      
SSI 76.0% 84.4% 67.5% 96.9% 97.9% 
      
Percent who are high 
cost in post-period 51.7% 39.8% 39.1% 40.4% 63.6% 
      
Observations 1502 1542 1503 1499 681 
            
 
     Table 6 presents differences between the pre- and post-PMHP implementation 
for each of the high-cost groups.  We also present differences for the overall sample 
for comparison.  Overall, there are significant declines in penetration, service days, 
and costs for all four samples after implementation of the PMHP.  The declines are 
greatest among individuals with the highest prior period costs, suggesting some 
problems with a “regression to the mean”.  Thus, despite post period utilization being 
highest among the group with the highest pre-PMHP costs, there are substantial 
declines between the two time periods.  As discussed earlier, the use of the 
prospective model avoids some of the complications with high cost individuals in one 
period typically having a decline in use in future periods.  The prospective model 
classifies individuals based on the expected costs in the future.  Even among this 
group, utilization declines. 
 
Table 6     
Changes between base and post periods 
 
 Measure of high cost    
 Cost  
Concurr
ent  
Concur
rent  
Prosp
ective Cost + Overall 
Variable     
predicti
on  residual  
predic
tion  
Prospe
ctive  sample 
Penetration       
Inpatient 
-
24.0% * -11.9% * -19.8% *
-
10.3% * -27.2% * -1.1% 
Outpatient -3.7% * -4.0% * -2.6% * -3.1% * -6.2% * -0.7% 
Psychiatric -8.5% * -6.5% * -8.5% * -4.2% * -7.6% * 0.3% 
CMH -9.7%  -13.5% * -14.8% * -9.8% -9.4% -8.2% 
Medical 
-
11.3% * -10.9% * -6.5% * -5.1% -13.7% * -3.8% 
Other -0.7%  -1.8% * -0.6%  -1.2% * -2.1% 0.0% 
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Cost            
Inpatient -$4,029 * -$2,931 * -$3,651 * -$2,717 * -$6,306 * -$320
Outpatient -$14 * -$12 * -$11 * -$5  -$19 * -$1
Psychiatric -$65 * -$46 * -$76 * -$34 * -$76 * -$7
CMH -$1,360 * -$850 * -$1,102 * -$763 * -$1,444 * -$208
Medical -$23 * -$14  -$50 * $41  -$70  $40
Other $23 * -$9  $19 * $8  $28  $1
            
Observations 1502  1542  1503  1499  681  14948
Note: * indicates the difference from the overall sample is significant at the 5 percent level. 
 
Conclusion 
     This brief sub-study examined two questions.  First, can diagnosis based case mix 
models identify future high cost enrollees better than prior use models?  Second, 
how did high cost enrollees fare during the transition from fee-for-service to 
managed care for mental health services? 
  
     Overall, a combination of prior use and the prospective risk model identified 
future high cost users better than any individual method.  These results suggest that 
future high cost individuals can be identified and potentially targeted for 
intervention.  However, regardless of the method used to classify high cost 
individuals, those classified as high cost users saw significant declines in treatment 
with the transition to managed care.  The declines were found across the broad 
service categories.  Given the use of broad service categories, future research may 
focus on specific services that were affected by the transition to managed care. 
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